O-I Glass (OI) 10-K 10 Feb 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Jan. 31, 2017	Jun. 30, 2016
Document and Entity Information
Entity Registrant Name	OWENS ILLINOIS INC /DE/
Entity Central Index Key	812,074
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 3,717,494,000
Entity Common Stock, Shares Outstanding		162,354,026
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY

CONSOLIDATED RESULTS OF OPERATI

CONSOLIDATED RESULTS OF OPERATIONS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED RESULTS OF OPERATIONS
Net sales	$ 6,702	$ 6,156	$ 6,784
Cost of goods sold	(5,490)	(5,046)	(5,531)
Gross profit	1,212	1,110	1,253
Selling and administrative expense	(503)	(476)	(523)
Research, development and engineering expense	(65)	(64)	(63)
Interest expense, net	(272)	(251)	(230)
Equity earnings	60	60	64
Other expense, net	(76)	(111)	(194)
Earnings from continuing operations before income taxes	356	268	307
Provision for income taxes	(119)	(106)	(92)
Earnings from continuing operations	237	162	215
Loss from discontinued operations	(7)	(4)	(23)
Net earnings	230	158	192
Net (earnings) attributable to noncontrolling interests	(21)	(23)	(28)
Net earnings	209	135	164
Amounts attributable to the Company:
Earnings from continuing operations	216	139	187
Loss from discontinued operations	(7)	(4)	(23)
Net earnings	$ 209	$ 135	$ 164
Basic earnings per share:
Earnings from continuing operations (in dollars per share)	$ 1.33	$ 0.86	$ 1.14
Loss from discontinued operations (in dollars per share)	(0.04)	(0.03)	(0.14)
Net earnings (in dollars per share)	1.29	0.83	1
Diluted earnings per share:
Earnings from continuing operations (in dollars per share)	1.32	0.85	1.13
Loss from discontinued operations (in dollars per share)	(0.04)	(0.03)	(0.14)
Net earnings (in dollars per share)	$ 1.28	$ 0.82	$ 0.99

CONSOLIDATED COMPREHENSIVE INCO

CONSOLIDATED COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED COMPREHENSIVE INCOME
Net earnings	$ 230	$ 158	$ 192
Other comprehensive loss:
Foreign currency translation adjustments	(224)	(529)	(305)
Pension and other postretirement benefit adjustments, net of tax	52	(4)	(90)
Change in fair value of derivative instruments, net of tax	13	(6)	1
Other comprehensive loss	(159)	(539)	(394)
Total comprehensive income (loss)	71	(381)	(202)
Comprehensive income attributable to noncontrolling interests	(17)	(7)	(7)
Comprehensive income (loss) attributable to the Company	$ 54	$ (388)	$ (209)

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 492	$ 399
Trade receivables, net of allowances of $32 million and $29 million at December 31, 2016 and 2015, respectively	580	562
Inventories	983	1,007
Prepaid expenses and other current assets	199	366
Total current assets	2,254	2,334
Other assets:
Equity investments	433	409
Pension assets	40	32
Other assets	602	599
Intangibles	464	597
Goodwill	2,462	2,489
Total other assets	4,001	4,126
Property, plant and equipment:
Land, at cost	241	252
Buildings and equipment, at cost:
Buildings and building equipment	1,090	1,123
Factory machinery and equipment	4,496	4,526
Transportation, office and miscellaneous equipment	85	88
Construction in progress	238	238
Property, plant and equipment, at cost	6,150	6,227
Less accumulated depreciation	3,270	3,266
Net property, plant and equipment	2,880	2,961
Total assets	9,135	9,421
Current liabilities:
Accounts payable	1,135	1,212
Salaries and wages	174	145
U.S. and foreign income taxes	58	36
Current portion of asbestos-related liabilities	115	130
Other accrued liabilities	383	371
Short-term loans	162	160
Long-term debt due within one year	33	68
Total current liabilities	2,060	2,122
Long-term debt	5,133	5,345
Deferred taxes	100	124
Pension benefits	552	504
Nonpension postretirement benefits	162	155
Other liabilities	188	205
Asbestos-related liabilities	577	687
Share owners' equity of the Company:
Common stock, par value $.01 per share, 250,000,000 shares authorized, 185,354,796 and 184,480,646 shares issued (including treasury shares), respectively	2	2
Capital in excess of par value	3,080	3,064
Treasury stock, at cost, 23,017,367 and 23,519,049 shares, respectively	(560)	(573)
Retained loss	(96)	(305)
Accumulated other comprehensive loss	(2,172)	(2,017)
Total share owners' equity of the Company	254	171
Noncontrolling interests	109	108
Total share owners' equity	363	279
Total liabilities and share owners' equity	$ 9,135	$ 9,421

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
CONSOLIDATED BALANCE SHEETS
Trade receivables allowance	$ 32	$ 29
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	185,354,796	184,480,646
Treasury stock, shares	23,017,367	23,519,049

CONSOLIDATED SHARE OWNERS' EQUI

CONSOLIDATED SHARE OWNERS' EQUITY - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Common Stock
Increase (Decrease) in Share Owners' Equity
Balance	$ 2	$ 2	$ 2
Balance	2	2	2
Capital in Excess of Par Value
Increase (Decrease) in Share Owners' Equity
Balance	3,064	3,066	3,040
Issuance of common stock (0.3, 0.2 and 0.3 million shares for the year ended December 31, 2016, 2015 and 2014, respectively)	5	1	5
Stock compensation	11	15	21
Acquisitions of noncontrolling interest		(18)
Balance	3,080	3,064	3,066
Treasury Stock
Increase (Decrease) in Share Owners' Equity
Balance	(573)	(480)	(454)
Reissuance of common stock (0.1, 0.3 and 0.2 million shares for year ended December 31, 2016, 2015 and 2014, respectively)	13	7	6
Treasury shares purchased (4.1 and 1.1 million shares for year ended December 31, 2015 and 2014, respectively)		(100)	(32)
Balance	(560)	(573)	(480)
Retained Earnings (Loss)
Increase (Decrease) in Share Owners' Equity
Balance	(305)	(440)	(604)
Net earnings	209	135	164
Balance	(96)	(305)	(440)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Share Owners' Equity
Balance	(2,017)	(1,494)	(1,121)
Other comprehensive income (loss)	(155)	(523)	(373)
Balance	(2,172)	(2,017)	(1,494)
Non-controlling Interests
Increase (Decrease) in Share Owners' Equity
Balance	108	117	147
Net earnings	21	23	28
Other comprehensive income (loss)	(4)	(16)	(21)
Distributions to noncontrolling interests	(16)	(22)	(37)
Acquisitions of noncontrolling interest		6
Balance	109	108	117
Balance	279	771	1,010
Issuance of common stock (0.3, 0.2 and 0.3 million shares for the year ended December 31, 2016, 2015 and 2014, respectively)	$ 5	$ 1	$ 5
Issuance of common stock (in shares)	0.3	0.2	0.3
Reissuance of common stock (0.1, 0.3 and 0.2 million shares for year ended December 31, 2016, 2015 and 2014, respectively)	$ 13	$ 7	$ 6
Reissuance of common stock (in shares)	0.1	0.3	0.2
Treasury shares purchased (4.1 and 1.1 million shares for year ended December 31, 2015 and 2014, respectively)		$ (100)	$ (32)
Treasury shares purchased (in shares)		4.1	1.1
Stock compensation	$ 11	$ 15	$ 21
Net earnings	230	158	192
Other comprehensive income (loss)	(159)	(539)	(394)
Distributions to noncontrolling interests	(16)	(22)	(37)
Acquisitions of noncontrolling interest		(12)
Balance	$ 363	$ 279	$ 771

CONSOLIDATED SHARE OWNERS' EQU7

CONSOLIDATED SHARE OWNERS' EQUITY (Parenthetical) - shares shares in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED SHARE OWNERS' EQUITY
Issuance of common stock (in shares)	0.3	0.2	0.3
Reissuance of common stock (in shares)	0.1	0.3	0.2
Treasury shares purchased (in shares)		4.1	1.1

CONSOLIDATED CASH FLOWS

CONSOLIDATED CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating activities:
Net earnings	$ 230	$ 158	$ 192
Loss from discontinued operations	7	4	23
Non-cash charges (credits):
Depreciation	375	323	335
Amortization of intangibles and other deferred items	103	86	83
Amortization of finance fees and debt discount	13	15	30
Deferred tax provision (benefit)	(4)	12	(18)
Pension expense	31	31	43
Restructuring, asset impairment and related charges	98	63	76
Pension settlement charges	98		65
Impairment of equity investment	25
Gain on China land sale	(71)
Non-income tax charge			69
Asbestos-related costs		16	46
Acquisition-related fair value inventory adjustments		22
Acquisition-related fair value intangible adjustments		10
Pension contributions	(38)	(17)	(28)
Asbestos-related payments	(125)	(138)	(148)
Cash paid for restructuring activities	(24)	(38)	(58)
Change in components of working capital	90	88	117
Other	(50)	(23)	(129)
Cash provided by continuing operating activities	758	612	698
Cash utilized in discontinued operating activities	(7)	(4)	(23)
Total cash provided by operating activities	751	608	675
Investing activities:
Additions to property, plant and equipment	(454)	(402)	(369)
Acquisitions, net of cash acquired	(56)	(2,351)	(114)
Net cash proceeds related to sale of assets and other	85	1	19
Net foreign exchange derivative activity	8	4
Net activity for non-controlling partner loans			9
Cash utilized in investing activities	(417)	(2,748)	(455)
Financing activities:
Additions to long-term debt	1,235	4,538	1,247
Repayments of long-term debt	(1,453)	(2,321)	(1,101)
Increase (decrease) in short-term loans	10	51	(139)
Payment of finance fees	(9)	(90)	(11)
Distributions paid to noncontrolling interests	(16)	(22)	(37)
Treasury shares purchased		(100)	(32)
Issuance of common stock and other	5	1	3
Cash provided by (utilized in) financing activities	(228)	2,057	(70)
Effect of exchange rate fluctuations on cash	(13)	(30)	(21)
Increase (decrease) in cash	93	(113)	129
Cash and cash equivalents at beginning of period	399	512	383
Cash and cash equivalents at end of period	$ 492	$ 399	$ 512

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Significant Accounting Policies
Significant Accounting Policies	1. Significant Accounting Poli Basis of Consolidated Statements The consolidated financial statements of Owens-Illinois, Inc. (the “Company”) include the accounts of its subsidiaries. Newly acquired subsidiaries have been included in the consolidated financial statements from dates of acquisition. The Company uses the equity method of accounting for investments in which it has a significant ownership interest, generally 20% to 50%. Other investments are accounted for at cost. The Company monitors other than temporary declines in fair value and records reductions in carrying values when appropriate. Nature of Operations The Company is a leading manufacturer of glass container products. The Company’s principal product lines are glass containers for the food and beverage industries. The Company has glass container operations located in 23 countries. The principal markets and operations for the Company’s products are in Europe, North America, Latin America and Asia Pacific. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management of the Company to make estimates and assumptions that affect certain amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates, at which time the Company would revise its estimates accordingly. Foreign Currency Translation The assets and liabilities of non-U.S. subsidiaries are translated into U.S. dollars at year-end exchange rates. Any related translation adjustments are recorded in accumulated other comprehensive income in share owners’ equity. Revenue Recognition The Company recognizes sales, net of estimated discounts and allowances, when the title to the products and risk of loss are transferred to customers. Provisions for rebates to customers are provided in the same period that the related sales are recorded. Shipping and Handling Costs Shipping and handling costs are included with cost of goods sold in the Consolidated Results of Operations. Stock-Based Compensation The Company has various stock-based compensation plans consisting of stock option grants and restricted share awards. Costs resulting from all share-based compensation plans are required to be recognized in the financial statements. A public entity is required to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. That cost is recognized over the required service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the required service. Cash The Company defines “cash” as cash and time deposits with maturities of three months or less when purchased. Outstanding checks in excess of funds on deposit are included in accounts payable. Accounts Receivable Receivables are stated at amounts estimated by management to be the net realizable value. The Company charges off accounts receivable when it becomes apparent based upon age or customer circumstances that amounts will not be collected. Allowance for Doubtful Accounts The allowance for doubtful accounts is established through charges to the provision for bad debts. The Company evaluates the adequacy of the allowance for doubtful accounts on a periodic basis. The evaluation includes historical trends in collections and write-offs, management’s judgment of the probability of collecting accounts and management’s evaluation of business risk. Inventory Valuation Inventories are valued at the lower of average costs or market. Goodwill Goodwill represents the excess of cost over fair value of net assets of businesses acquired. Goodwill is evaluated annually, as of October 1, for impairment or more frequently if an impairment indicator exists. Intangible Assets and Other Long-Lived Assets Intangible assets are amortized over the expected useful life of the asset. Amortization expense directly attributed to the manufacturing of the Company’s products is included in cost of goods sold. Amortization expense related to non-manufacturing activities is included in selling and administrative and other. The Company evaluates the recoverability of intangible assets and other long-lived assets based on undiscounted projected cash flows, excluding interest and taxes, when factors indicate that impairment may exist. If impairment exists, the asset is written down to fair value. Property, Plant and Equipment Property, plant and equipment (“PP&E”) is carried at cost and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. In general, depreciation is computed using the straight-line method and recorded over the estimated useful life of the asset. Factory machinery and equipment is depreciated over periods ranging from 5 to 25 years with the majority of such assets (principally glass-melting furnaces and forming machines) depreciated over 7 to 15 years. Buildings and building equipment are depreciated over periods ranging from 10 to 50 years. Depreciation expense directly attributed to the manufacturing of the Company’s products is included in cost of goods sold. Depreciation expense related to non-manufacturing activities is included in selling and administrative. Depreciation expense includes the amortization of assets recorded under capital leases. Maintenance and repairs are expensed as incurred. Costs assigned to PP&E of acquired businesses are based on estimated fair values at the date of acquisition. The Company evaluates the recoverability of PP&E based on undiscounted projected cash flows, excluding interest and taxes, when factors indicate that impairment may exist. If impairment exists, the asset is written down to fair value. Derivative Instruments The Company uses forward exchange contracts, options and commodity forward contracts to manage risks generally associated with foreign exchange rate and commodity market volatility. Derivative financial instruments are included on the balance sheet at fair value. When appropriate, derivative instruments are designated as and are effective as hedges, in accordance with accounting principles generally accepted in the United States. If the underlying hedged transaction ceases to exist, all changes in fair value of the related derivatives that have not been settled are recognized in current earnings. The Company does not enter into derivative financial instruments for trading purposes and is not a party to leveraged derivatives. Cash flows from forward exchange contracts not designated as hedges are classified as an investing activity. Cash flows of commodity forward contracts are classified as operating activities. Fair Value Measurements Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Generally accepted accounting principles defines a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to develop assumptions. The carrying amounts reported for cash and short-term loans approximate fair value. In addition, carrying amounts approximate fair value for certain long-term debt obligations subject to frequently redetermined interest rates. Fair values for the Company’s significant fixed rate debt obligations are generally based on published market quotations. The Company’s derivative assets and liabilities consist of natural gas forwards and foreign exchange option and forward contracts. The Company uses an income approach to valuing these contracts. Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates counterparty risk in determining fair values. Reclassifications Certain reclassifications of prior years’ data have been made to conform to the current year presentation. New Accounting Standards Revenue from Contracts with Customers - In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers," which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. In August 2015, the FASB issued ASU No. 2015-14, “Revenue from Contracts with Customers”, which delayed by one year the effective date of the new revenue recognition standard, which will be effective for the Company on January 1, 2018. The Company has started an implementation process, including a review of customer contracts, to evaluate the effect this standard will have on its consolidated financial statements and related disclosures. At this time, the Company does not expect that the implementation of this standard in 2018 will have a significant impact on the timing in which it recognizes revenue. While the Company continues to assess the potential impacts of the new standard, the Company does not currently expect the adoption of the new standard to have a material impact on consolidated net income or the consolidated balance sheet. The Company plans to select the modified retrospective transition method upon adoption effective January 1, 2018. Leases - In February 2016, the FASB issued ASU No. 2016-02, “Leases”. Under this guidance, lessees will be required to recognize on the balance sheet a lease liability and a right-of-use asset for all leases, with the exception of short-term leases. The lease liability represents the lessee's obligation to make lease payments arising from a lease, and will be measured as the present value of the lease payments. The right-of-use asset represents the lessee’s right to use a specified asset for the lease term, and will be measured at the lease liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs. The standard also requires a lessee to recognize a single lease cost allocated over the lease term, generally on a straight-line basis. The new guidance is effective for the Company on January 1, 2019. ASU No. 2016-02 is required to be applied using the modified retrospective approach for all leases existing as of the effective date and provides for certain practical expedients. Early adoption is permitted. The Company is currently evaluating the effects that the adoption of ASU No. 2016-02 will have on the Company’s consolidated financial statements, and anticipates the new guidance will significantly impact its consolidated financial statements as the Company has a significant number of leases. As further described in Note 16, Operating Leases, as of December 31, 2016, the Company had minimum lease commitments under non-cancellable operating leases totaling $205 million. Credit Losses - In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. This guidance also requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses. The new guidance is effective for the Company on January 1, 2020. Early adoption is permitted for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements. Stock Compensation - In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting,” which requires all excess tax benefits or deficiencies to be recognized as income tax expense or benefit in the income statement. In addition, excess tax benefits should be classified along with other income tax cash flows as an operating activity in the statement of cash flows. Application of the standard is required for the Company on January 1, 2017. The Company does not expect a significant impact in its Consolidated Financial Statements. Pension Asset Value - In May 2015, the FASB issued ASU No. 2015-07, “Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share (or Its Equivalent).” Under the new guidance, investments measured at net asset value (“NAV”), as a practical expedient for fair value, are excluded from the fair value hierarchy. Removing investments measured using the practical expedient from the fair value hierarchy is intended to eliminate the diversity in practice that currently exists with respect to the categorization of these investments. The new guidance is effective for the Company on January 1, 2016. The guidance impacted the presentation of certain pension related assets that use NAV as a practical expedient. See Note 9 for additional information.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2016
Segment Information
Segment Information	2. Segment Information The Company has four reportable segments based on its geographic locations: Europe, North America, Latin America and Asia Pacific. In connection with the Company’s acquisition (the “Vitro Acquisition”) of the food and beverage glass container business of Vitro S.A.B. de C.V. and its subsidiaries as conducted in the United States, Mexico and Bolivia (the “Vitro Business”) on September 1, 2015 (see Note 19), the Company has renamed the former South America segment to the Latin America segment. These four segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, and certain equity investments. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments. The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations as well as certain retained corporate costs. The Company’s management uses segment operating profit, in combination with selected cash flow information, to evaluate performance and to allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Financial information regarding the Company’s reportable segments is as follows: 2016 2015 2014 Net sales: Europe $ $ $ North America Latin America Asia Pacific Reportable segment totals Other Net sales $ $ $ 2016 2015 2014 Segment operating profit: Europe $ $ $ North America Latin America Asia Pacific Reportable segment totals Items excluded from segment operating profit: Retained corporate costs and other Charge for asbestos-related costs Restructuring, asset impairment and other charges Pension settlement charges Gain on China land sale Strategic transaction costs Acquisition-related fair value inventory adjustments Acquisition-related fair value intangible adjustments Non-income tax charge Interest expense, net Earnings from continuing operations before income taxes $ $ $ Reportable Retained Consoli- North Latin Asia Segment Corp Costs dated Europe America America Pacific Totals and Other Totals Total assets: 2016 $ $ $ $ $ $ $ 2015 2014 Equity investments: 2016 $ $ $ — $ $ $ $ 2015 2014 Equity earnings: 2016 $ $ $ — $ $ $ $ 2015 2014 Capital expenditures: 2016 $ $ $ $ $ $ $ 2015 2014 Depreciation and amortization expense: 2016 $ $ $ $ $ $ $ 2015 2014 The Company’s net property, plant and equipment by geographic segment are as follows: U.S. Non-U.S. Total 2016 $ $ $ 2015 2014 The Company’s net sales by geographic segment are as follows: U.S. Non-U.S. Total 2016 $ $ $ 2015 2014 Intercompany sales in Latin America totaled $195 million, $101 million and $0 for the years ended December 31, 2016, 2015, and 2014, respectively. Operations outside the U.S. that accounted for more than 10% of consolidated net sales from continuing operations were in France (2015 — 10%, 2014 — 11%).

Inventories

Inventories	12 Months Ended
	Dec. 31, 2016
Inventories
Inventories	3. Inventories Major classes of inventory are as follows: 2016 2015 Finished goods $ $ Raw materials Operating supplies $ $

Equity Investments

Equity Investments	12 Months Ended
	Dec. 31, 2016
Equity Investments
Equity Investments	4. Equity Investments At December 31, 2016 the Company’s ownership percentage in affiliates include: O-I Ownership Affiliates Percentage Business Type BJC O-I Glass Pte. Ltd. % Glass container manufacturer CO Vidrieria SARL ("COV") % Glass container manufacturer Rocky Mountain Bottle Company % Glass container manufacturer Tata Chemical (Soda Ash) Partners % Soda ash supplier Vetrerie Meridionali SpA ("VeMe") % Glass container manufacturer Vetri Speciali SpA % Specialty glass manufacturer Summarized information pertaining to the Company’s equity affiliates follows: 2016 2015 2014 Equity in earnings: Non-U.S. $ $ $ U.S. Total $ $ $ Dividends received $ $ $ Summarized combined financial information for equity affiliates is as follows (unaudited): 2016 2015 At end of year: Current assets $ $ Non-current assets Total assets Current liabilities Other liabilities and deferred items Total liabilities and deferred items Net assets $ $ For the year: 2016 2015 2014 Net sales $ $ $ Gross profit $ $ $ Net earnings $ $ $ Based on an evaluation of each of the Company’s equity investments for the three years ending December 31, 2016, no investments exceeded the significant subsidiary thresholds per Rule 3-09 of Regulation S-X. As such, separate financial statements for the Company’s equity investments are not required to be filed. The Company made purchases of approximately $176 million and $161 million from equity affiliates in 2016 and 2015, respectively, and owed approximately $76 million and $66 million to equity affiliates as of December 31, 2016 and 2015, respectively. There is a difference of approximately $12 million as of December 31, 2016, between the amount at which certain investments are carried and the amount of underlying equity in net assets. The portion of the difference related to inventory or amortizable assets is amortized as a reduction of the equity earnings. The remaining difference is considered goodwill.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets
Goodwill and Intangible Assets	5. Goodwill and Intangible Assets Goodwill The changes in the carrying amount of goodwill for the years ended December 31, 2016, 2015 and 2014 are as follows: North Latin Europe America America Other Total Balance as of January 1, 2014 $ $ $ $ $ Translation effects Balance as of December 31, 2014 Acquisition related adjustments Translation effects Balance as of December 31, 2015 Acquisition related adjustments Translation effects Balance as of December 31, 2016 $ $ $ $ $ The acquisition related adjustments in 2016 and 2015 primarily relate to the Vitro Acquisition (see Note 19). Goodwill for the Asia Pacific segment is $0 and net of accumulated impairment losses of $1,135 million as of December 31, 2016, 2015 and 2014. Goodwill is tested for impairment annually as of October 1 (or more frequently if impairment indicators arise) using a two-step process. Step 1 compares the business enterprise value (“BEV”) of each reporting unit with its carrying value. The BEV is computed based on estimated future cash flows, discounted at the weighted average cost of capital of a hypothetical third-party buyer. If the BEV is less than the carrying value for any reporting unit, then Step 2 must be performed. Step 2 compares the implied fair value of goodwill with the carrying amount of goodwill. Any excess of the carrying value of the goodwill over the implied fair value will be recorded as an impairment loss. The calculations of the BEV in Step 1 and the implied fair value of goodwill in Step 2 are based on significant unobservable inputs, such as price trends, customer demand, material costs, discount rates and asset replacement costs, and are classified as Level 3 in the fair value hierarchy. During the fourth quarter of 2016, the Company completed its annual impairment testing and determined that no impairment existed. Intangible assets On September 1, 2015, the Company acquired customer list intangibles as part of the Vitro Acquisition (see Note 19). Customer list intangible assets are amortized using the accelerated amortization method over their 20 year lives. Net intangible asset values were $464 million and $597 million for the years ended December 31, 2016 and 2015, respectively. Amortization expense for intangible assets was $39 million, $21 million and $1 million for the years ended December 31, 2016, 2015 and 2014, respectively. Estimated amortization related to intangible assets through 2021 is as follows: 2017, $44 million; 2018, $44 million; 2019, $42 million; 2020, $41 million; and 2021, $39 million. No impairment existed on these assets at December 31, 2016. The Company has determined that the fair value measurements related to the customer list intangibles are based on significant unobservable inputs and are classified as Level 3 in the fair value hierarchy.

Prepaid Expenses and Other Asse

Prepaid Expenses and Other Assets	12 Months Ended
	Dec. 31, 2016
Prepaid Expenses and Other Assets
Prepaid Expenses and Other Assets	6. Prepaid Expenses and Other Assets Prepaid expenses and other current assets at December 31, 2016 and 2015 are as follows: 2016 2015 Prepaid expenses $ $ Value added taxes Other $ $ Other assets (noncurrent) consist of the following at December 31, 2016 and 2015: 2016 2015 Deferred tax assets $ $ Deferred returnable packaging costs Repair part inventories Capitalized software Value added taxes Deferred finance fees Other $ $ Capitalized software includes costs related to the acquisition and development of internal-use software. These costs are amortized over the estimated useful life of the software. Amortization expense for capitalized software was $13 million, $19 million and $17 million for 2016, 2015 and 2014, respectively. Estimated amortization related to capitalized software through 2021 is as follows: 2017, $14 million; 2018, $14 million; 2019, $13 million; 2020, $12 million; and 2021, $11 million.

Derivative Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2016
Derivative Instruments
Derivative Instruments	7. Derivative Instruments The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign exchange option and forward contracts. The Company uses an income approach to value these contracts. Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates counterparty risk in determining fair values. Commodity Forward Contracts Designated as Cash Flow Hedges In North America, the Company enters into commodity forward contracts related to forecasted natural gas requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows. The Company continually evaluates the natural gas market and related price risk and periodically enters into commodity forward contracts in order to hedge a portion of its usage requirements. The majority of the sales volume in North America is tied to customer contracts that contain provisions that pass the price of natural gas to the customer. In certain of these contracts, the customer has the option of fixing the natural gas price component for a specified period of time. At December 31, 2016 and 2015, the Company had entered into commodity forward contracts covering approximately 12,300,000 MM BTUs and 7,300,000 MM BTUs, respectively, primarily related to customer requests to lock the price of natural gas. The Company accounts for the above forward contracts as cash flow hedges at December 31, 2016 and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified into earnings in the same period or periods during which the underlying hedged item affects earnings. An unrecognized gain of $6 million at December 31, 2016 and an unrecognized loss of $4 million at December 31, 2015 related to the commodity forward contracts were included in Accumulated OCI, and will be reclassified into earnings over the next twelve to twenty-four months. Any material portion of the change in the fair value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current earnings. The ineffectiveness related to these natural gas hedges for the year ended December 31, 2016 and 2015 was not material. The effect of the commodity forward contracts on the results of operations for the years ended December 31, 2016, 2015 and 2014 is as follows: Amount of gain (loss) Reclassified from Amount of gain (loss) Recognized in OCI on Accumulated OCI into Income Commodity Forward Contracts (reported in cost of goods sold) (Effective Portion) (Effective Portion) 2016 2015 2014 2016 2015 2014 $ $ $ $ — $ (1) $ 2 Foreign Exchange Derivative Contracts and not Designated as Hedging Instruments The Company may enter into short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company may also use forward exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables, payables and loans, not denominated in, or indexed to, their functional currencies. The Company records these short-term forward exchange agreements on the balance sheet at fair value and changes in the fair value are recognized in current earnings. At December 31, 2016 and 2015, the Company had outstanding forward exchange and option agreements denominated in various currencies covering the equivalent of approximately $490 million and $790 million, respectively, related primarily to intercompany transactions and loans. The effect of the foreign exchange derivative contracts on the results of operations for the years ended December 31, 2016, 2015 and 2014 is as follows: Amount of Gain (Loss) Location of Gain (Loss) Recognized in Income on Recognized in Income on Foreign Exchange Contracts Foreign Exchange Contracts 2016 2015 2014 Other expense, net $ $ $ Balance Sheet Classification The Company records the fair values of derivative financial instruments on the balance sheet as follows: (a) receivables if the instrument has a positive fair value and maturity within one year, (b) deposits, receivables, and other assets if the instrument has a positive fair value and maturity after one year, and (c) other accrued liabilities or other liabilities (current) if the instrument has a negative fair value and maturity within one year. The following table shows the amount and classification (as noted above) of the Company’s derivatives as of December 31, 2016 and 2015: Fair Value Balance Sheet Location 2016 2015 Asset Derivatives: Derivatives designated as hedging instruments: Commodity futures contracts b $ $ — Derivatives not designated as hedging instruments: Foreign exchange derivative contracts a $ $ Total asset derivatives $ $ Liability Derivatives: Derivatives designated as hedging instruments: Commodity futures contracts c $ — $ Derivatives not designated as hedging instruments: Foreign exchange derivative contracts c Total liability derivatives $ $

Restructuring Accruals, Asset I

Restructuring Accruals, Asset Impairments and Other Costs Related to Closed Facilities	12 Months Ended
	Dec. 31, 2016
Restructuring Accruals, Asset Impairments and Other Costs Related to Closed Facilities
Restructuring Accruals, Asset Impairments and Other Costs Related to Closed Facilities	8. Restructuring Accruals, Asset Impairments and Other Costs Related to Closed Facilities The Company continually reviews its manufacturing footprint and operating cost structure and may decide to close operations or reduce headcount to gain efficiencies, integrate acquired operations, reduce future expenses and other market factors. The Company incurs costs associated with these actions including employee severance and benefits, other exit costs such as those related to contract terminations, and asset impairment charges. The Company also may incur other costs related to closed facilities including environmental remediation, clean up, dismantling and preparation for sale or other disposition. The Company accounts for restructuring and other costs under applicable provisions of generally accepted accounting principles. Charges for employee severance and related benefits are generally accrued based on contractual arrangements with employees or their representatives. Other exit costs are accrued based on the estimated cost to settle related contractual arrangements. Estimated environmental remediation costs are accrued when specific claims have been received or are probable of being received. The Company’s decisions to curtail selected production capacity have resulted in write downs of certain long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell. The Company classified the significant assumptions used to determine the fair value of the impaired assets as Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. When a decision is made to take these actions, the Company manages and accounts for them programmatically apart from the on-going operations of the business. Information related to major programs (as in the case of the European Asset Optimization and Asia Pacific Restructuring programs below) are presented separately. Minor initiatives are presented on a combined basis as Other Restructuring Actions. These restructuring initiatives taken by the Company are not related to the European Asset Optimization program or the Asia Pacific restructuring plan. When charges related to major programs are completed, remaining accrual balances are classified with Other Restructuring Actions. European Asset Optimization In 2011, the Company initiated the European Asset Optimization program to increase the efficiency and capability of its European operations and to better align its European manufacturing footprint with market and customer needs. This program involved making additional investments in certain facilities and addressing assets with higher cost structures. As part of this program, the Company recorded charges of $0, $0, and $1 million for the years ended 2016, 2015 and 2014, respectively for employee costs, write-down of assets, and environmental remediation related to decisions to close furnaces and manufacturing facilities in Europe. The Company recorded total cumulative charges of $127 million and does not expect to execute any further actions under this program. Asia Pacific Restructuring Since 2011, the Company has implemented a restructuring plan in its Asia Pacific segment, primarily related to aligning its supply base with lower demand in the region. As part of this plan, the Company recorded charges of $4 million, $5 million and $73 million for the years ended 2016, 2015 and 2014, respectively, for employee costs, write-down of assets, and pension charges related to furnace closures and additional restructuring activities. The Company recorded total cumulative charges of $224 million and does not expect to execute any further actions under this program. Other Restructuring Actions In 2016, the Company recorded charges of $94 million for other restructuring actions. These charges primarily represented employee costs, write-down of assets, and other exit costs of $64 million for plant closures in Latin America, Europe, and North America and $30 million related to other restructuring actions. The Company took certain other restructuring actions and recorded charges in 2015 of $58 million. These charges primarily related to employee costs, write-down of assets and other exit costs totaling $14 million for a plant closure and furnace closure in Latin America, $38 million for a plant closure in North America and $6 million for other restructuring actions. In 2014, the Company took certain other restructuring actions and recorded charges of $2 million for employee costs related to global headcount reduction initiatives. The following table presents information related to restructuring, asset impairment and other costs related to closed facilities from January 1, 2015 through December 31, 2015: European Other Asset Asia Pacific Restructuring Total Optimization Restructuring Actions Restructuring Balance at January 1, 2015 $ $ $ $ Charges Write-down of assets to net realizable value Net cash paid, principally severance and related benefits Other, including foreign exchange translation Balance at December 31, 2015 $ $ $ $ The following table presents information related to restructuring, asset impairment and other costs related to closed facilities from January 1, 2016 through December 31, 2016: Other Asia Pacific Restructuring Total Restructuring Actions Restructuring Balance at January 1, 2016 $ $ $ Charges Write-down of assets to net realizable value Net cash paid, principally severance and related benefits Other, including foreign exchange translation Balance at December 31, 2016 $ $ $ The restructuring accrual balance represents the Company’s estimates of the remaining future cash amounts to be paid related to the actions noted above. As of December 31, 2016, the Company’s estimates include approximately $67 million for employee benefits costs, $16 million for environmental remediation costs, and $2 million for other exit costs.

Pension Benefit Plans and Other

Pension Benefit Plans and Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2016
Pension Benefit Plans and Other Postretirement Benefits
Pension Benefit Plans and Other Postretirement Benefits	9. Pension Benefit Plans and Other Postretirement Benefits Pension Benefit Plans The Company has defined benefit pension plans covering a substantial number of employees located in the United States and several other non-U.S. jurisdictions. Benefits generally are based on compensation for salaried employees and on length of service for hourly employees. The Company’s policy is to fund pension plans such that sufficient assets will be available to meet future benefit requirements. The Company’s defined benefit pension plans use a December 31 measurement date. The following tables relate to the Company’s principal defined benefit pension plans. The changes in the pension benefit obligations for the year are as follows: U.S. Non-U.S. 2016 2015 2016 2015 Obligations at beginning of year $ $ $ $ Change in benefit obligations: Service cost Interest cost Actuarial (gain) loss, including the effect of change in discount rates Curtailment, settlement, and plan amendment Acquisitions Participant contributions Benefit payments Other Foreign currency translation Net change in benefit obligations Obligations at end of year $ $ $ $ The changes in the fair value of the pension plans’ assets for the year are as follows: U.S. Non-U.S. 2016 2015 2016 2015 Fair value at beginning of year $ $ $ $ Change in fair value: Actual gain (loss) on plan assets Benefit payments Employer contributions Participant contributions Settlements Acquisitions Foreign currency translation Other Net change in fair value of assets Fair value at end of year $ $ $ $ The Company recognizes the funded status of each pension benefit plan on the balance sheet. The funded status of each plan is measured as the difference between the fair value of plan assets and actuarially calculated benefit obligations as of the balance sheet date. Actuarial gains and losses are accumulated in Other Comprehensive Income and the portion of each plan that exceeds 10% of the greater of that plan’s assets or projected benefit obligation is amortized to income on a straight-line basis over the average remaining service period of employees still accruing benefits or the expected life of participants not accruing benefits if all, or almost all, of the plan’s participants are no longer accruing benefits. The funded status of the pension plans at year end is as follows: U.S. Non-U.S. 2016 2015 2016 2015 Plan assets at fair value $ $ $ $ Projected benefit obligations Plan assets less than projected benefit obligations Items not yet recognized in pension expense: Actuarial loss Prior service cost (credit) Net amount recognized $ $ $ $ The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2016 and 2015 as follows: U.S. Non-U.S. 2016 2015 2016 2015 Pension assets $ — $ — $ $ Current pension liability, included with other accrued liabilities Pension benefits Accumulated other comprehensive loss Net amount recognized $ $ $ $ The following changes in plan assets and benefit obligations were recognized in accumulated other comprehensive income at December 31, 2016 and 2015 as follows (amounts are pretax): U.S. Non-U.S. 2016 2015 2016 2015 Current year actuarial (gain) loss $ $ $ $ Amortization of actuarial loss Settlement — Translation $ $ $ $ The accumulated benefit obligation for all defined benefit pension plans was $3,126 million and $3,306 million at December 31, 2016 and 2015, respectively. The components of the net pension expense for the year are as follows: U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Service cost $ $ $ $ $ $ Interest cost Expected asset return Amortization: Actuarial loss Prior service credit Net amortization Net expense $ $ $ $ $ $ Effective January 1, 2016 the Company amended its salary pension plan in North America to freeze future pension benefits. This action required an obligation remeasurement for the curtailment of benefits, which resulted in a reduction of the Company’s pension expense. In 2016, the Company settled a portion of the U.S. Hourly Pension Plan obligation, which resulted in a settlement charge of $98 million. In 2014, the Company settled a portion of the U.S. Salary Pension Plan pension obligation, which resulted in a settlement charge of $30 million. On October 1, 2014, the Company settled the liability associated with its pension plan in the Netherlands, resulting in a settlement charge of approximately $35 million. Non-U.S. pension expense excludes $3 million of pension settlement costs that were recorded in restructuring expense in 2014. The table above excludes these charges. Amounts that are expected to be amortized from accumulated other comprehensive income into net pension expense during 2017: U.S. Non-U.S. Amortization: Actuarial loss $ $ Prior service cost Net amortization $ $ The following information is for plans with projected and accumulated benefit obligations in excess of the fair value of plan assets at year end: Projected Benefit Obligation Exceeds Accumulated Benefit Obligation Exceeds the Fair Value of Plan Assets the Fair Value of Plan Assets U.S. Non-U.S. U.S. Non-U.S. 2016 2015 2016 2015 2016 2015 2016 2015 Projected benefit obligations $ 1,956 $ $ $ $ 1,956 $ $ 897 $ Accumulated benefit obligation 1,956 1,956 867 Fair value of plan assets 1,654 1,654 632 The weighted average assumptions used to determine benefit obligations are as follows: U.S. Non-U.S. 2016 2015 2016 2015 Discount rate % % % % Rate of compensation increase N/A % % % The weighted average assumptions used to determine net periodic pension costs are as follows: U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Discount rate 4.43 % % % 3.68 % % % Rate of compensation increase 2.97 % % % 2.84 % % % Expected long-term rate of return on assets 7.50 % % % 7.15 % % % Future benefits are assumed to increase in a manner consistent with past experience of the plans, which, to the extent benefits are based on compensation, includes assumed salary increases as presented above. For 2016, the Company’s weighted average expected long-term rate of return on assets was 7.50% for the U.S. plans and 7.15% for the non-U.S. plans. In developing this assumption the Company considered its historical 10-year average return (through December 31, 2016) and evaluated input from its third party pension plan asset consultants, including their review of asset class return expectations. It is the Company’s policy to invest pension plan assets in a diversified portfolio consisting of an array of asset classes within established target asset allocation ranges. The investment risk of the assets is limited by appropriate diversification both within and between asset classes. The assets for the U.S. plans are maintained in a group trust. The U.S. plans hold no individual assets other than the investment in the group trust. The assets of the group trust and the Company’s non-U.S. plans are primarily invested in a broad mix of domestic and international equities, domestic and international bonds, and real estate, subject to the target asset allocation ranges. The assets are managed with a view to ensuring that sufficient liquidity will be available to meet expected cash flow requirements. The investment valuation policy of the Company is to value investments at fair value. All investments are valued at their respective net asset values. Equity securities for which market quotations are readily available are valued at the last reported sales price on their principal exchange on valuation date or official close for certain markets. Fixed income investments are valued by an independent pricing service. Investments in registered investment companies or collective pooled funds are valued at their respective net asset values. Short-term investments are stated at amortized cost, which approximates fair value. The fair value of real estate is determined by periodic appraisals. In accordance with the Company’s adoption of ASU No. 2015-07 in 2016, certain investments measured at net asset value (“NAV”), as a practical expedient for fair value, have been excluded from the fair value hierarchy. The fair value measurements tables presented below have been amended to conform to the current year presentation under ASU No. 2015-07. See Note 1 for more information. The Company’s U.S. pension plan assets held in the group trust are measured at net asset value in the fair value hierarchy. The total U.S. plan assets amounted to $1,654 million and $1,909 million as of December 31, 2016 and 2015, respectively. In 2016, the U.S. plan assets consisted of approximately 62% equity securities, 31% debt securities, and 7% real estate and other. In 2016, the non-U.S. plan assets consisted of approximately 41% equity securities, 42% debt securities, and 17% real estate and other. The following table sets forth by level, within the fair value hierarchy, the Company’s non-U.S. pension plan assets at fair value as of December 31, 2016 and 2015: 2016 2015 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash and cash equivalents $ $ — $ — $ $ $ — $ — $ Equity securities — — Debt securities Real estate Other Total $ $ $ $ $ $ Investments measured at net asset value $ $ Total non-U.S. assets at fair value $ $ The following is a reconciliation of the Company’s pension plan assets recorded at fair value using significant unobservable inputs (Level 3): 2016 2015 Beginning balance $ $ Net increase (decrease) Ending balance $ $ The net increase (decrease) in the fair value of the Company’s Level 3 pension plan assets is primarily due to purchases and sales of unlisted real estate funds. The change in the fair value of Level 3 pension plan assets due to actual return on those assets was immaterial in 2016. In order to maintain minimum funding requirements, the Company is required to make contributions to its defined benefit pension plans of $32 million in 2017. The following estimated future benefit payments, which reflect expected future service, as appropriate, are expected to be paid in the years indicated: Year(s) U.S. Non-U.S. 2017 $ $ 2018 2019 2020 2021 2022-2026 The Company also sponsors several defined contribution plans for all salaried and hourly U.S. employees, and employees in Canada, the U.K., The Netherlands and Australia. Participants’ contributions are based on their compensation. The Company matches contributions of participants, up to various limits, in substantially all plans. Company contributions to these plans amounted to $34 million in 2016, $29 million in 2015, and $19 million in 2014. Postretirement Benefits Other Than Pensions The Company provides retiree health care and life insurance benefits covering certain U.S. salaried and hourly employees, and substantially all employees in Canada. Benefits provided by the Company for hourly retirees are determined by collective bargaining. Employees are generally eligible for benefits upon retirement and completion of a specified number of years of creditable service. The Company uses a December 31 measurement date to measure its postretirement benefit obligations. The changes in the postretirement benefit obligations for the year are as follows: U.S. Non-U.S. 2016 2015 2016 2015 Obligations at beginning of year $ $ $ $ Change in benefit obligations: Service cost Interest cost Actuarial (gain) loss, including the effect of changing discount rates Benefit payments Foreign currency translation Other Net change in benefit obligations Obligations at end of year $ $ $ $ The funded status of the postretirement benefit plans at year end is as follows: U.S. Non-U.S. 2016 2015 2016 2015 Postretirement benefit obligations $ $ $ $ Items not yet recognized in net postretirement benefit cost: Actuarial gain (loss) Prior service credit Net amount recognized $ $ $ $ The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2016 and 2015 as follows: U.S. Non-U.S. 2016 2015 2016 2015 Current nonpension postretirement benefit, included with Other accrued liabilities $ $ $ $ Nonpension postretirement benefits Accumulated other comprehensive income (loss) Net amount recognized $ $ $ $ The following changes in benefit obligations were recognized in accumulated other comprehensive income at December 31, 2016 and 2015 as follows (amounts are pretax): U.S. Non-U.S. 2016 2015 2016 2015 Current year actuarial (gain) loss $ $ $ $ — Amortization of actuarial loss Amortization of prior service credit $ $ $ $ — The components of the net postretirement benefit cost for the year are as follows: U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Service cost $ — $ — $ — $ $ $ Interest cost Curtailment gain Amortization: Actuarial loss Prior service credit Net amortization — — — Net postretirement benefit (income) cost $ $ $ $ $ $ Amounts that are expected to be amortized from accumulated other comprehensive income into net postretirement benefit cost during 2017: U.S. Non-U.S. Amortization: Actuarial loss $ $ — Prior service credit Net amortization $ $ — Amortization included in net postretirement benefit cost is based on the average remaining service of employees. The weighted average discount rates used to determine the accumulated postretirement benefit obligation and net postretirement benefit cost are as follows: U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Accumulated postretirement benefit obligation % % % % % % Net postretirement benefit cost % % % % % % The weighted average assumed health care cost trend rates at December 31 are as follows: U.S. Non-U.S. 2016 2015 2016 2015 Health care cost trend rate assumed for next year % % % % Rate to which the cost trend rate is assumed to decline (ultimate trend rate) % % % % Year that the rate reaches the ultimate trend rate N/A N/A Assumed health care cost trend rates affect the amounts reported for the postretirement benefit plans. A one-percentage-point change in assumed health care cost trend rates would have the following effects: U.S. Non-U.S. 1-Percentage-Point 1-Percentage-Point Increase Decrease Increase Decrease Effect on total of service and interest cost $ — $ — $ $ Effect on accumulated postretirement benefit obligations Amortization included in net postretirement benefit cost is based on the average remaining service of employees. The following estimated future benefit payments, which reflect expected future service, as appropriate, are expected to be paid in the years indicated: Year(s) U.S. Non-U.S. 2017 $ $ 2018 2019 2020 2021 2022 - 2026 Other U.S. hourly retirees receive health and life insurance benefits from a multi-employer trust established by collective bargaining. Payments to the trust as required by the bargaining agreements are based upon specified amounts per hour worked and were $6 million in 2016, $6 million in 2015 and $6 million in 2014. Postretirement health and life benefits for retirees of foreign subsidiaries are generally provided through the national health care programs of the countries in which the subsidiaries are located.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2016
Income Taxes
Income Taxes	10. Income Taxes The provision for income taxes was calculated based on the following components of earnings (loss) before income taxes: Continuing operations 2016 2015 2014 U.S. $ $ — $ Non-U.S. $ $ $ Discontinued operations 2016 2015 2014 U.S. $ — $ — $ Non-U.S. $ $ $ The provision (benefit) for income taxes consists of the following: 2016 2015 2014 Current: U.S. $ — $ $ Non-U.S. Deferred: U.S. — Non-U.S. Total: U.S. Non-U.S. Total for continuing operations Total for discontinued operations — — — $ $ $ A reconciliation of the provision for income taxes based on the statutory U.S. Federal tax rate of 35% to the provision for income taxes is as follows: 2016 2015 2014 Tax provision on pretax earnings from continuing operations at statutory U.S. Federal tax rate $ $ $ Increase (decrease) in provision for income taxes due to: Non-U.S. tax rates Changes in valuation allowance Withholding tax, net Non-deductible acquisition costs U.S. tax on intercompany dividends and interest Tax exempt income Intraperiod tax allocation Tax law changes Tax credit Changes in tax reserves Mexico inflationary adjustments Other items Provision for income taxes $ $ $ Deferred income taxes reflect: (1) the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes; and (2) carryovers and credits for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities at December 31, 2016 and 2015 are as follows: 2016 2015 Deferred tax assets: Accrued postretirement benefits $ $ Asbestos-related liabilities Foreign tax credit Operating and capital loss carryovers Other credit carryovers Accrued liabilities Pension liability Other Total deferred tax assets Deferred tax liabilities: Property, plant and equipment Intangibles and deferred software Other Total deferred tax liabilities Valuation allowance Net deferred taxes $ $ Deferred taxes are included in the Consolidated Balance Sheets at December 31, 2016 and 2015 as follows: 2016 2015 Other assets $ $ Deferred taxes Net deferred taxes $ $ The Company reviews the likelihood that it will realize the benefit of its deferred tax assets and therefore the need for valuation allowances on a quarterly basis, or whenever events indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or consolidated group recording the net deferred tax asset is considered, along with other positive and negative evidence. At December 31, 2016, before valuation allowance, the Company had unused foreign tax credits of $413 million expiring in 2017 through 2026, research tax credits of $14 million expiring from 2019 to 2036, and alternative minimum tax credits of $18 million which do not expire and which will be available to offset future U.S. Federal income tax. Approximately $151 million of the deferred tax assets related to operating and capital loss carryforwards can be carried over indefinitely, with the remaining $238 million expiring between 2017 and 2036. In certain jurisdictions, the Company’s analysis indicates that it has cumulative losses in recent years. This is considered significant negative evidence which is objective and verifiable and, therefore, difficult to overcome. However, the cumulative loss position is not solely determinative and, accordingly, the Company considers all other available positive and negative evidence in its analysis. Based on its analysis, the Company has recorded a valuation allowance for the portion of deferred tax assets where based on the weight of available evidence it is unlikely to realize those deferred tax assets. At December 31, 2016, the Company’s equity in the undistributed earnings of foreign subsidiaries for which income taxes had not been provided approximated $2.2 billion. The Company intends to reinvest these earnings indefinitely in the non-U.S. operations. It is not practicable to estimate the U.S. and foreign tax which would be payable should these earnings be distributed. Deferred taxes are provided for earnings of non-U.S. jurisdictions when the Company plans to remit those earnings. The Company records a liability for unrecognized tax benefits related to uncertain tax positions. The Company accrues interest and penalties associated with unrecognized tax benefits as a component of its income tax expense. The following is a reconciliation of the Company’s total gross unrecognized tax benefits for the years ended December 31, 2016, 2015 and 2014: 2016 2015 2014 Balance at January 1 $ $ $ Additions and reductions for tax positions of prior years Additions based on tax positions related to the current year Reductions due to the lapse of the applicable statute of limitations Reductions due to settlements Foreign currency translation Balance at December 31 $ $ $ Unrecognized tax benefits, which if recognized, would impact the Company’s effective income tax rate $ $ $ Accrued interest and penalties at December 31 $ $ $ Interest and penalties included in tax expense for the years ended December 31 $ $ $ Based upon the outcome of tax examinations, judicial proceedings, or expiration of statute of limitations, it is reasonably possible that the ultimate resolution of these unrecognized tax benefits may result in a payment that is materially different from the current estimate of the tax liabilities. The Company believes that it is reasonably possible that the estimated liability could decrease up to $11 million within the next 12 months. This is primarily the result of audit settlements or statute expirations in several taxing jurisdictions. The Company is currently under examination in various tax jurisdictions in which it operates, including Argentina, Bolivia, Brazil, China, Canada, Colombia, Ecuador, France, Germany, Indonesia, and Italy. The years under examination range from 2006 through 2014. The Company has received tax assessments in excess of established reserves. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact to the Company’s results of operations, financial position or cash flows. During 2016, the Company concluded income tax audits in several jurisdictions, including the Czech Republic, Germany, Italy, and Hungary.

Debt

Debt	12 Months Ended
	Dec. 31, 2016
Debt
Debt	11. Debt The following table summarizes the long-term debt of the Company at December 31, 2016 and 2015: 2016 2015 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ — $ — Term Loans: Term Loan A Term Loan A (€279 million at December 31, 2016) Term Loan B Senior Notes: 6.75%, due 2020 (€500 million) 4.875%, due 2021 (€330 million) 5.00%, due 2022 5.875%, due 2023 3.125%, due 2024 (€500 million) 5.375%, due 2025 6.375%, due 2025 Senior Debentures: 7.80%, due 2018 Capital leases Other Total long-term debt Less amounts due within one year Long-term debt $ $ On April 22, 2015, the Company entered into a Senior Secured Credit Facility, which subsequently has been amended several times with the most recent amendment being entered into on February 3, 2016 (the “Amended Agreement”). In connection with the closing of the Vitro Acquisition on September 1, 2015 (see Note 19), the Company incurred $1,250 million of senior secured incremental term loan facilities, comprised of (i) a $675 million term loan A facility on substantially the same terms and conditions (including as to maturity) as the term loan A facility in the Amended Agreement and (ii) a $575 million term loan B facility, which was subsequently repaid in full in November 2016 as described below. At December 31, 2016, the Amended Agreement includes a $300 million revolving credit facility, a $600 million multicurrency revolving credit facility, a $1,575 million term loan A facility ($1,395 million net of debt issuance costs), and a €279 million term loan A facility ($282 million net of debt issuance costs), each of which has a final maturity date of April 22, 2020. At December 31, 2016, the Company had unused credit of $884 million available under the Amended Agreement. The weighted average interest rate on borrowings outstanding under the Amended Agreement at December 31, 2016 was 2.39%. The Amended Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations. The Amended Agreement also contains one financial covenant, a Total Leverage Ratio, that requires the Company not to exceed a ratio calculated by dividing consolidated total debt, less cash and cash equivalents, by consolidated EBITDA, as defined in the Amended Agreement. The Total Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Total Leverage Ratio to exceed the specified maximum of (i) 4.5x for the four fiscal quarters ending December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, and (ii) 4.0x for the fourth fiscal quarter ending December 31, 2017 and each fiscal quarter thereafter. Failure to comply with these covenants and restrictions could result in an event of default under the Amended Agreement. In such an event, the Company would be unable to request borrowings under the revolving facility, and all amounts outstanding under the Amended Agreement, together with accrued interest, could then be declared immediately due and payable. If an event of default occurs under the Amended Agreement and the lenders cause all of the outstanding debt obligations under the Amended Agreement to become due and payable, this would result in a default under a number of other outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of December 31, 2016, the Company was in compliance with all covenants and restrictions in the Amended Agreement. In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the Amended Agreement will not be adversely affected by the covenants and restrictions. The interest rates on borrowings under the Amended Agreement are, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the Amended Agreement, plus an applicable margin. The applicable margin for the term loan A facility and the revolving credit facility is linked to the Company’s Total Leverage Ratio and ranges from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for Base Rate loans. In addition, a facility fee is payable on the revolving credit facility commitments ranging from 0.20% to 0.30% per annum linked to the Total Leverage Ratio. Borrowings under the Amended Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Borrowings are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign subsidiaries. All borrowings under the Amended Agreement are guaranteed by certain domestic subsidiaries of the Company. Also, in connection with the Vitro Acquisition, during August 2015, the Company issued senior notes with a face value of $700 million that bear interest at 5.875% and are due August 15, 2023 (the “Senior Notes due 2023”) and senior notes with a face value of $300 million that bear interest at 6.375% and are due August 15, 2025 (together with the Senior Notes due 2023, the “2015 Senior Notes”). The 2015 Senior Notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds from the 2015 Senior Notes, after deducting the debt discount and debt issuance costs, totaled approximately $972 million and were used to finance, in part, the Vitro Acquisition. During November 2016, the Company issued senior notes with a face value of €500 million that bear interest at 3.125% and are due November 15, 2024. The notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting the debt discount and debt issuance costs, totaled approximately $520 million and were used to repay the term loan B facility under the Amended Agreement. The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market. The Company has a €185 million European accounts receivable securitization program, which extends through March 2019, subject to periodic renewal of backup credit lines. Information related to the Company’s accounts receivable securitization program as of December 31, 2016 and 2015 is as follows: 2016 2015 Balance (included in short-term loans) $ $ Weighted average interest rate % % The carrying amounts reported for the accounts receivable securitization program, and certain long-term debt obligations subject to frequently redetermined interest rates, approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy. Annual maturities for all of the Company’s long-term debt through 2021 are as follows: 2017, $33 million; 2018, $287 million; 2019, $101 million; 2020, $2,074 million; and 2021, $354 million. Fair values at December 31, 2016, of the Company’s significant fixed rate debt obligations are as follows: Principal Indicated Amount Market Price Fair Value Senior Notes: 6.75%, due 2020 (€500 million) $ $ $ 4.875%, due 2021 (€330 million) 5.00%, due 2022 5.875%, due 2023 3.125%, due 2024 (€500 million) 6.375%, due 2025 5.375%, due 2025 Senior Debentures: 7.80%, due 2018

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2016
Contingencies
Contingencies	12. Contingencies Asbestos The Company is a defendant in numerous lawsuits alleging bodily injury and death as a result of exposure to asbestos. From 1948 to 1958, one of the Company's former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos. The Company sold its insulation business unit at the end of April 1958. The typical asbestos personal injury lawsuit alleges various theories of liability, including negligence, gross negligence and strict liability and seeks compensatory and, in some cases, punitive damages in various amounts (herein referred to as "asbestos claims"). The following table shows the approximate number of plaintiffs and claimants who had asbestos claims pending against the Company at the beginning of each listed year, the number of claims disposed of during that year, the year’s filings and the claims pending at the end of each listed year (eliminating duplicate filings): 2016 2015 2014 Pending at beginning of year Disposed Filed Pending at end of year Based on an analysis of the lawsuits pending as of December 31, 2016, approximately 88% of plaintiffs either do not specify the monetary damages sought, or in the case of court filings, claim an amount sufficient to invoke the jurisdictional minimum of the trial court. Approximately 9% of plaintiffs specifically plead damages above the jurisdictional minimum up to, and including, $15 million or less, and 3% of plaintiffs specifically plead damages greater than $15 million but less than or equal to $100 million. As indicated by the foregoing summary, current pleading practice permits considerable variation in the assertion of monetary damages. The Company’s experience resolving hundreds of thousands of asbestos claims and lawsuits over an extended period demonstrates that the monetary relief alleged in a complaint bears little relevance to a claim’s merits or disposition value. Rather, the amount potentially recoverable is determined by such factors as the type and severity of the plaintiff’s asbestos disease, the plaintiff’s medical history and exposure to other disease-causing agents, the product identification evidence against the Company and other co-defendants, the defenses available to the Company and other co-defendants, the specific jurisdiction in which the claim is made, and the plaintiff’s firm representing the claimant. In addition to the pending claims set forth above, the Company has claims-handling agreements in place with many plaintiffs’ counsel throughout the country. These agreements require evaluation and negotiation regarding whether particular claimants qualify under the criteria established by such agreements. The criteria for such claims include verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company's former business unit during its manufacturing period ending in 1958. The Company has also been a defendant in other asbestos-related lawsuits or claims involving maritime workers, medical monitoring claimants, co-defendants and property damage claimants. Based upon its past experience, the Company believes that these categories of lawsuits and claims will not involve any material liability and they are not included in the above description of pending matters or in the following description of disposed matters. Since receiving its first asbestos claim, the Company as of December 31, 2016, has disposed of the asbestos claims of approximately 398,000 plaintiffs and claimants at an average indemnity payment per claim of approximately $9,000. The Company’s asbestos indemnity payments have varied on a per claim basis, and are expected to continue to vary considerably over time. Asbestos-related cash payments for 2016, 2015 and 2014 were $125 million, $138 million, and $148 million, respectively. The Company’s cash payments per claim disposed (inclusive of legal costs) were approximately $71,000, $95,000 and $81,000 for the years ended December 31, 2016, 2015 and 2014, respectively. As discussed above, the Company’s objective is to achieve, where possible, resolution of asbestos claims pursuant to claims-handling agreements. Failure of claimants to meet certain medical and product exposure criteria in the Company’s administrative claims handling agreements has generally reduced the number of claims that would otherwise have been received by the Company in the tort system. In addition, certain court orders and legislative acts have reduced or eliminated the number of claims that the Company otherwise would have received by the Company in the tort system. These developments generally have had the effect of increasing the Company’s per-claim average indemnity payment over time. Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total of approximately $4.9 billion through 2016, before insurance recoveries, for its asbestos-related liability. The Company’s estimates of its liability have been significantly affected by, among other factors, the volatility of asbestos-related litigation in the United States, the significant number of co-defendants that have filed for bankruptcy, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the significant expansion of the defendants that are now sued in this litigation, and the continuing changes in the extent to which these defendants participate in the resolution of cases in which the Company is also a defendant. The Company continues to monitor trends that may affect its ultimate liability and analyze the developments and variables likely to affect the resolution of pending and future asbestos claims against the Company. The material components of the Company’s total accrued liability are determined by the Company in connection with its annual comprehensive legal review and consist of the following estimates, to the extent it is probable that such liabilities have been incurred and can be reasonably estimated: (i) the liability for asbestos claims already asserted against the Company; (ii) the liability for asbestos claims not yet asserted against the Company; and (iii) the legal defense costs estimated to be incurred in connection with the claims already asserted and those claims the Company believes will be asserted. As noted above, the Company conducts a comprehensive legal review of its asbestos-related liabilities and costs annually in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments warrant an earlier review. As part of its current annual comprehensive legal review, the Company provides historical claims filing data to a third party with expertise in determining the impact of disease incidence and mortality on future filing trends to develop information to assist the Company in estimating the total number of future claims to be filed. The Company uses this estimate of total future claims, along with an estimation of disposition costs and related legal costs, as inputs to develop its best estimate of its total probable liability. If the results of the annual comprehensive legal review indicate that the existing amount of the accrued liability is lower (higher) than its reasonably estimable asbestos-related costs, then the Company will record an appropriate charge (credit) to the Company’s results of operations to increase (decrease) the accrued liability. The significant assumptions underlying the material components of the Company’s accrual are: a) settlements will continue to be limited almost exclusively to claimants who were exposed to the Company’s asbestos‑containing insulation prior to its exit from that business in 1958; b) claims will continue to be resolved primarily under the Company’s administrative claims agreements or on terms comparable to those set forth in those agreements; c) the incidence of serious asbestos‑related disease cases and claiming patterns against the Company for such cases do not change materially; d) the Company is substantially able to defend itself successfully at trial and on appeal; e) the number and timing of additional co‑defendant bankruptcies do not change significantly the assets available to participate in the resolution of cases in which the Company is a defendant; and f) co‑defendants with substantial resources and assets continue to participate significantly in the resolution of future asbestos lawsuits and claims. For the years ended December 31, 2016 and 2015, the Company concluded that accruals in the amounts of $692 million and $817 million, respectively, were required. These amounts have not been discounted for the time value of money. The Company’s comprehensive legal reviews resulted in charges of $0, $16 million and $46 million for the years ended December 31, 2016, 2015 and 2014, respectively. The Company believes it is reasonably possible that it will incur a loss for its asbestos-related liabilities in excess of the amount currently recognized, which is $692 million as of December 31, 2016. The Company estimates that reasonably possible losses could be as high as $825 million. This estimate of additional reasonably possible loss reflects a legal judgment about the number and cost of potential future claims and legal costs. The Company believes this estimate is consistent with the level of variability it has experienced when comparing actual results to recent near-term projections. However, it is also possible that the ultimate asbestos-related liability could be above this estimate. The Company expects a significant majority of the total number of claims to be received in the next ten years. This timeframe appropriately reflects the mortality of current and expected claimants in light of the Company’s sale of its insulation business unit in 1958. As noted above, the Company’s asbestos-related liability is based on a projection of new claims that will eventually be filed against the Company and the estimated average disposition cost of these claims and related legal costs. Changes in these projections, and estimates, as well as changes in the significant assumptions noted above, have the potential to significantly impact the estimation of the Company’s asbestos-related liability. Other Matters The Company’s joint venture in China had been involved in litigation with its partner regarding whether the joint venture should be dissolved. Following an ownership change in 2016 with respect to the joint venture partner, this litigation has been withdrawn. On July 5, 2016, the Company learned that the Enforcement Division of the SEC is conducting an investigation into certain accounting and control matters pertaining to the Company’s determination of its asbestos-related liabilities. On May 13, 2016, the Company restated its consolidated financial statements for the years ended December 31, 2015, 2014 and 2013 in order to correct an error related to the Company’s method for estimating its future asbestos-related liabilities. The Company is cooperating with the SEC’s investigation. At this time, the Company is unable to predict the outcome of this matter or provide meaningful quantification of how the final resolution of this matter may impact its future consolidated financial statements, results of operations, or cash flows. Other litigation is pending against the Company, in many cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2016
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)	13. Accumulated Other Comprehensive Income (Loss) The components of comprehensive income are: (a) net earnings; (b) change in fair value of certain derivative instruments; (c) pension and other postretirement benefit adjustments; and (d) foreign currency translation adjustments. The net effect of exchange rate fluctuations generally reflects changes in the relative strength of the U.S. dollar against major foreign currencies between the beginning and end of the year. The following table lists the beginning balance, annual activity and ending balance of each component of accumulated other comprehensive income (loss): Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Income (Loss) Balance on January 1, 2015 $ $ $ $ Change before reclassifications Amounts reclassified from accumulated other comprehensive income (a) (b) Translation effect Tax effect Other comprehensive income (loss) attributable to the Company Balance on December 31, 2015 Change before reclassifications Amounts reclassified from accumulated other comprehensive income (a) (b) Translation effect Tax effect Intraperiod tax allocation Other comprehensive income (loss) attributable to the Company Balance on December 31, 2016 $ $ $ $ (a) Amount is included in Cost of goods sold on the Consolidated Results of Operations (see Note 7 for additional information). (b) Amount is included in the computation of net periodic pension cost and net postretirement benefit cost (see Note 9 for additional information).

Stock Options and Other Stock B

Stock Options and Other Stock Based Compensation	12 Months Ended
	Dec. 31, 2016
Stock Options and Other Stock Based Compensation
Stock Options and Other Stock Based Compensation	14. Stock Options and Other Stock Based Compensation The Company has various nonqualified plans approved by share owners under which it has granted stock options, restricted shares and performance vested restricted share units. At December 31, 2016, there were 5,081,000 shares available for grants under these plans. Total compensation cost for all grants of shares and units under these plans was $15 million, $15 million and $21 million for the years ended December 31, 2016, 2015 and 2014, respectively. Stock Options In general, subject to change in control, options become exercisable 25% per year beginning on the first anniversary of grant. No options may be exercised in whole or in part during the first year after the date granted. In general, options expire following termination of employment or the seventh anniversary of the option grant. The fair value of options is amortized over the vesting periods which range from one to four years. Stock option information at December 31, 2016 and for the year then ended is as follows: Weighted Weighted Average Average Remaining Number of Exercise Contractual Aggregate Shares Price Term Intrinsic (thousands) (per share) (years) Value Options outstanding at January 1, 2016 $ Granted Exercised Forfeited or expired Options outstanding at December 31, 2016 $ Options vested or expected to vest at December 31, 2016 $ $ Options exercisable at December 31, 2016 $ $ — Certain additional information related to stock options is as follows for the periods indicated: 2016 2015 2014 Weighted average grant-date fair value of options granted (per share) $ $ $ Aggregate intrinsic value of options exercised $ $ — $ Aggregate cash received from options exercised $ $ $ The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions: 2016 2015 2014 Expected life of options (years) Expected stock price volatility % % % Risk-free interest rate % % % Expected dividend yield % % % The expected life of options is determined from historical exercise and termination data. The expected stock price volatility is determined by reference to historical prices over a period equal to the expected life. Restricted Shares and Restricted Share Units Shares granted after March 21, 2005 and prior to 2011, vest 25% per year beginning on the first anniversary and unvested shares are forfeited upon termination of employment. Restricted share units granted to employees after 2010 vest 25% per year beginning on the first anniversary. Holders of vested restricted share units receive one share of the Company’s common stock for each unit as units vest. Granted but unvested restricted share units are forfeited upon termination, unless certain retirement criteria are met. Restricted share units granted to directors vest after one year. The fair value of the restricted shares and restricted share units is equal to the market price of the Company’s common stock on the date of the grant. The fair value of restricted shares and restricted share units, is amortized over the vesting periods which range from one to four years. The activity of restricted shares and restricted share units is as follows: Weighted Number of Average Restricted Grant-Date Shares Fair Value (thousands) (per share) Nonvested at January 1, 2016 $ Granted Vested Forfeited Nonvested at December 31, 2016 Awards granted during 2015 $ Awards granted during 2014 $ 2016 2015 2014 Total fair value of shares vested $ $ $ Performance Vested Restricted Share Units Performance vested restricted share units vest on January 1 of the third year following the year in which they are granted. Holders of vested units may receive up to 2 shares of the Company’s common stock for each unit, depending upon the attainment of consolidated performance goals established by the Compensation Committee of the Company’s Board of Directors. If minimum goals are not met, no shares will be issued. Granted but unvested restricted share units are forfeited upon termination of employment, unless certain retirement criteria are met. The fair value of each performance vested restricted share unit is equal to the product of the fair value of the Company’s common stock on the date of grant and the estimated number of shares into which the performance vested restricted share unit will be converted. The fair value of performance vested restricted share units is amortized ratably over the vesting period. Should the estimated number of shares into which the performance vested restricted share unit will be converted change, an adjustment will be recorded to recognize the accumulated difference in amortization between the revised and previous estimates. Performance vested restricted share unit activity is as follows: Number of Performance Weighted Average Vested Restricted Shares Grant-Date Fair Value Units (thousands) (per unit) Nonvested at January 1, 2016 $ Granted Vested Forfeited/Cancelled Nonvested at December 31, 2016 Awards granted during 2015 $ Awards granted during 2014 $ Approximately 158,000 shares were issued in 2016 with a fair value at issuance date of $4 million related to performance vested restricted share units. As of December 31, 2016, there was $17 million of total unrecognized compensation cost related to all unvested stock options, restricted shares, restricted share units and performance vested restricted share units. That cost is expected to be recognized over a weighted average period of approximately two years.

Other Expense, net

Other Expense, net	12 Months Ended
	Dec. 31, 2016
Other Expense, net
Other Expense, net	15. Other Expense, net Other expense, net for the years ended December 31, 2016, 2015 and 2014 included the following: 2016 2015 2014 Restructuring, asset impairment and other charges $ $ $ Intangible amortization expense Impairment of equity investment Charge for asbestos related costs Gain on China land compensation Royalty income Strategic transaction costs Acquisition-related fair value intangible adjustments Non-income tax charge Foreign currency exchange loss (gain) Other expense (income) $ $ $ In 2016, the Company evaluated the future estimated earnings and cash flow of an equity investment and determined that it was other-than-temporarily impaired. As such, the Company recorded an impairment charge of $25 million to reduce its carrying value down to its estimated fair value. The Company classified the significant assumptions used to determine the fair value of the impaired assets as Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. In 2014, the Company recorded a charge of $69 million resulting from a non-income tax assessment from a foreign tax authority.

Operating Leases

Operating Leases	12 Months Ended
	Dec. 31, 2016
Operating Leases
Operating Leases	16. Operating Leases Rent expense attributable to all warehouse, office buildings and equipment operating leases was $80 million in 2016, $72 million in 2015, and $63 million in 2014. Minimum future rentals under operating leases are as follows: 2017, $65 million; 2018, $47 million; 2019, $32 million; 2020, $23 million; 2021, $14 million; and 2022 and thereafter, $24 million.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2016
Earnings Per Share
Earnings Per Share	17. Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share: 2016 2015 2014 Numerator: Net earnings attributable to the Company $ $ $ Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding Effect of dilutive securities: Stock options and other Denominator for diluted earnings per share-adjusted weighted average shares outstanding Basic earnings per share: Earnings from continuing operations $ $ $ Loss from discontinued operations Net earnings $ $ $ Diluted earnings per share: Earnings from continuing operations $ $ $ Loss from discontinued operations Net earnings $ $ $ Options to purchase 2,770,458, 1,937,315 and 1,143,933 weighted average shares of common stock which were outstanding during 2016, 2015 and 2014, respectively, were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2016
Supplemental Cash Flow Information
Supplemental Cash Flow Information	18. Supplemental Cash Flow Information Changes in the components of working capital related to operations (net of the effects related to acquisitions and divestitures) were as follows: 2016 2015 2014 Decrease (increase) in current assets: Receivables $ $ $ Inventories Prepaid expenses and other Increase (decrease) in current liabilities: Accounts payable Accrued liabilities Salaries and wages U.S. and foreign income taxes $ $ $ The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows. At December 31, 2016 and 2015, the amount of receivables sold by the Company was $318 million and $317 million, respectively. Any continuing involvement with the sold receivables is immaterial. 2016 2015 2014 Interest paid in cash $ $ $ Income taxes paid in cash (all non-U.S) Cash interest for the years ended December 31, 2016, 2015 and 2014 includes $9 million, $32 million and $9 million of note repurchase premiums, respectively.

Business Combinations

Business Combinations	12 Months Ended
	Dec. 31, 2016
Business Combinations
Business Combinations	19. Business Combinations On September 1, 2015, the Company completed the Vitro Acquisition in a cash transaction valued at approximately $2.297 billion in cash, subject to a working capital adjustment and certain other adjustments. The Vitro Business in Mexico is the largest supplier of glass containers in that country manufacturing glass containers across multiple end uses, including food, soft drinks, beer, wine and spirits. The Vitro Acquisition included five food and beverage glass container plants in Mexico, a plant in Bolivia and a North American distribution business, and provided the Company with a competitive position in the glass packaging market in Mexico. The results of the Vitro Business have been included in the Company’s consolidated financial statements since September 1, 2015 and contributed approximately $608 million of incremental net sales and $122 million of incremental segment operating profit in the year ended December 31, 2016. Vitro’s food and beverage glass container operations in Mexico and Bolivia are included in the Latin American operating segment while its distribution business is included in the North American operating segment. The Company financed the Vitro Acquisition with the proceeds from a senior notes offering, cash on hand and the incremental term loan facilities (see Note 11). The total purchase price was allocated to the tangible and identifiable intangible assets and liabilities based upon their respective fair values. The purchase agreement contained customary provisions for working capital adjustments, which the Company resolved with the seller in the first quarter of 2016. The Company completed the purchase price allocation process in the third quarter of 2016. The following table summarizes the fair value of the assets and liabilities assumed on September 1, 2015 and subsequent adjustments identified through the purchase price allocation process and recorded through the measurement period: September 1, 2015 Measurement Period Adjustments September 30, 2016 Cash $ $ — $ Other current assets Goodwill Customer list intangibles Net property, plant and equipment Total assets Current liabilities Long-term debt Long-term liabilities Net assets acquired $ $ — $ The fair value of the tangible assets was estimated utilizing income and market approaches, considering remaining useful life. The customer list intangible asset includes the Company’s established relationships with its customers and the ability of these customers to generate future economic profits for the Company. The value assigned to customer list intangibles is based on the present value of future earnings attributable to the asset group after recognition of required returns to other contributory assets. Recognized goodwill is attributable to the assembled workforce, expected synergies and other intangible assets that do not qualify for separate recognition. The Vitro Acquisition goodwill is not deductible for tax purposes. The balance sheet adjustments identified above did not result in any significant adjustments to the periods’ income statements.

Pro Forma Information - Vitro A

Pro Forma Information - Vitro Acquisition	12 Months Ended
	Dec. 31, 2016
Pro Forma Information – Vitro Acquisition
Pro Forma Information – Vitro Acquisition	20. Pro Forma Information – Vitro Acquisition Had the Vitro Acquisition, described in Note 19 and the related financing described in Note 11, occurred at the beginning of each respective period, unaudited pro forma consolidated net sales, earnings from continuing operations and earnings from continuing operations per share of common stock (diluted) would have been as follows: Year Ending December 31, 2015 As Acquisition Financing Pro Forma Reported Adjustments Adjustments As Adjusted Net sales $ $ $ — $ Earnings from continuing operations attributable to the Company $ $ $ $ Diluted earnings per share from continuing operations $ $

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2016
Discontinued Operations
Discontinued Operations	21. Discontinued Operations On April 4, 2016, the annulment committee formed by the World Bank’s International Centre for Settlement of Investment Disputes (“ICSID”) ruled that a subsidiary of the Company is free to pursue the enforcement of a prior arbitration award against Venezuela. That award amounts to more than $485 million after including interest from the date of the expropriation by Venezuela (October 26, 2010). Venezuela’s application to annul the award is still pending, although the annulment proceedings were suspended in October 2016 because Venezuela has not paid its fees owed to ICSID. If the proceeding is stayed for non-payment for a consecutive period in excess of six months, ICSID’s Secretary General could move that the committee discontinue the annulment proceeding altogether. The Company intends to take appropriate steps to vigorously enforce and collect the award, which is enforceable in approximately 150 member states that are party to the ICSID Convention. However, even with the lifting of the stay of enforcement, the Company recognizes that the collection of the award may present significant practical challenges. Because the award has yet to be satisfied and the annulment proceeding is pending, the Company is unable at this stage to reasonably predict the efforts that will be necessary to successfully enforce collection of the award, the amount of the award or the timing of any such collection efforts. Therefore, the Company has not recognized this award in its financial statements. A separate arbitration is pending with ICSID to obtain compensation primarily for third-party minority shareholders’ lost interests in the two expropriated plants. The loss from discontinued operations of $7 million and $4 million, for the years ended December 31, 2016 and 2015, respectively, relates to ongoing costs for the Venezuelan expropriation. The loss from discontinued operations of $23 million for the year ended December 31, 2014 included a settlement of a dispute with a purchaser of a previously disposed business, as well as ongoing costs related to the Venezuelan expropriation.

Financial Information for Subsi

Financial Information for Subsidiary Guarantors and Non-Guarantors	12 Months Ended
	Dec. 31, 2016
Financial Information for Subsidiary Guarantors and Non-Guarantors Disclosure
Financial Information for Subsidiary Guarantors and Non-Guarantors	22. Financial Information for Subsidiary Guarantors and Non-Guarantors The following presents condensed consolidating financial information for the Company, segregating: (1) Owens-Illinois, Inc., the issuer of senior debentures (the “Parent”); (2) the two subsidiaries which have guaranteed the senior debentures on a subordinated basis (the “Guarantor Subsidiaries”); and (3) all other subsidiaries (the “Non-Guarantor Subsidiaries”). The Guarantor Subsidiaries are 100% owned direct and indirect subsidiaries of the Company and their guarantees are full, unconditional and joint and several. They have no operations and function only as intermediate holding companies. Certain reclassifications have been made to conform all of the financial information to the financial presentation on a consolidated basis. The principal eliminations relate to investments in subsidiaries and intercompany balances and transactions. December 31, 2016 Guarantor Non-Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ $ — $ Trade receivables, net Inventories Prepaid expenses and other current assets Total current assets — — — Investments in and advances to subsidiaries — Property, plant and equipment, net Intangibles Goodwill Other assets Total assets $ $ $ $ $ Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ $ — $ Current portion of asbestos liability Accounts payable Other liabilities Total current liabilities — Long-term debt Asbestos-related liabilities Other long-term liabilities Share owners’ equity Noncontrolling interests Total liabilities and share owners’ equity $ $ $ $ $ December 31, 2015 Non- Guarantor Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ $ — $ Trade receivables, net Inventories Prepaid expenses and other current assets Total current assets — — — Investments in and advances to subsidiaries — Property, plant and equipment, net Intangibles Goodwill Other assets Total assets $ $ $ $ $ Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ $ — $ Current portion of asbestos liability Accounts payable Other liabilities Total current liabilities — Long-term debt Asbestos-related liabilities Other long-term liabilities Share owners’ equity Noncontrolling interests Total liabilities and share owners’ equity $ $ $ $ $ Year ended December 31, 2016 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ $ $ $ $ Cost of goods sold Gross profit Selling and administrative expense Research, development and engineering expense Net intercompany interest — Interest expense, net Equity earnings from subsidiaries — — Other equity earnings Other expense, net Earnings before income taxes Provision for income taxes Earnings from continuing operations Loss from discontinued operations Net earnings Net earnings attributable to noncontrolling interests Net earnings attributable to the Company $ $ $ $ $ Year ended December 31, 2016 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ $ $ $ $ Other comprehensive income (loss) Total comprehensive income (loss) Comprehensive income attributable to noncontrolling interests Comprehensive income (loss) attributable to the Company $ $ $ $ $ Year ended December 31, 2015 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ $ — $ Cost of goods sold Gross profit Selling and administrative expense Research, development and engineering expense Net intercompany interest — Interest expense, net Equity earnings from subsidiaries — Other equity earnings Other expense, net Earnings before income taxes Provision for income taxes Earnings from continuing operations Loss from discontinued operations Net earnings Net earnings attributable to noncontrolling interests Net earnings attributable to the Company $ $ $ $ $ Year ended December 31, 2015 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ $ $ $ $ Other comprehensive income (loss) Total comprehensive income (loss) Comprehensive income attributable to noncontrolling interests Comprehensive income (loss) attributable to the Company $ $ $ $ $ Year ended December 31, 2014 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ $ — $ Cost of goods sold Gross profit Selling and administrative expense Research, development and engineering expense Net intercompany interest — Interest expense, net Equity earnings from subsidiaries — Other equity earnings Other expense, net Earnings before income taxes Provision for income taxes Earnings from continuing operations Loss from discontinued operations Net earnings Net earnings attributable to noncontrolling interests Net earnings attributable to the Company $ $ $ $ $ Year ended December 31, 2014 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ $ $ $ $ Other comprehensive income (loss) Total comprehensive income (loss) Comprehensive income attributable to noncontrolling interests Comprehensive income (loss) attributable to the Company $ $ $ $ $ Year ended December 31, 2016 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ $ — $ $ — $ Cash utilized in investing activities Cash provided by (utilized in) financing activities Effect of exchange rate change on cash Net change in cash — — — Cash at beginning of period Cash at end of period $ — $ — $ $ — $ Year ended December 31, 2015 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ $ — $ $ — $ Cash utilized in investing activities Cash provided by financing activities Effect of exchange rate change on cash Net change in cash — — — Cash at beginning of period Cash at end of period $ — $ — $ $ — $ Year ended December 31, 2014 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ $ — $ $ — $ Cash utilized in investing activities Cash provided by (utilized in) financing activities Effect of exchange rate change on cash Net change in cash — — — Cash at beginning of period Cash at end of period $ — $ — $ $ — $

SCHEDULE II - VALUATION AND QUA

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (CONSOLIDATED)	12 Months Ended
	Dec. 31, 2016
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (CONSOLIDATED)
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (CONSOLIDATED)	OWENS-ILLINOIS, INC. SCHEDULE II – VALUATIO Years ended December 31, 2016, 2015, and 2014 (Millions of Dollars) Reserves deducted from assets in the balance sheets: Allowances for losses and discounts on receivables Additions Balance at Charged to Balance beginning costs and Deductions at end of of period expenses Other (Note 1) period 2016 $ $ $ $ $ 2015 $ $ $ $ $ 2014 $ $ $ $ $ (1) Deductions from allowances for losses and discounts on receivables represent uncollectible notes and accounts written off. Valuation allowance on net deferred tax assets Balance at Charged to other Balance at beginning of Charged to comprehensive Foreign currency end of period income income translation Other period 2016 $ $ $ $ $ $ 2015 $ $ $ $ $ $ 2014 $ $ $ $ $ $

Significant Accounting Polici32

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Significant Accounting Policies
Basis of Consolidated Statements	Basis of Consolidated Statements The consolidated financial statements of Owens-Illinois, Inc. (the “Company”) include the accounts of its subsidiaries. Newly acquired subsidiaries have been included in the consolidated financial statements from dates of acquisition. The Company uses the equity method of accounting for investments in which it has a significant ownership interest, generally 20% to 50%. Other investments are accounted for at cost. The Company monitors other than temporary declines in fair value and records reductions in carrying values when appropriate.
Nature of Operations	Nature of Operations The Company is a leading manufacturer of glass container products. The Company’s principal product lines are glass containers for the food and beverage industries. The Company has glass container operations located in 23 countries. The principal markets and operations for the Company’s products are in Europe, North America, Latin America and Asia Pacific.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management of the Company to make estimates and assumptions that affect certain amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates, at which time the Company would revise its estimates accordingly.
Foreign Currency Translation	Foreign Currency Translation The assets and liabilities of non-U.S. subsidiaries are translated into U.S. dollars at year-end exchange rates. Any related translation adjustments are recorded in accumulated other comprehensive income in share owners’ equity.
Revenue Recognition	Revenue Recognition The Company recognizes sales, net of estimated discounts and allowances, when the title to the products and risk of loss are transferred to customers. Provisions for rebates to customers are provided in the same period that the related sales are recorded.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and handling costs are included with cost of goods sold in the Consolidated Results of Operations.
Stock-Based Compensation	Stock-Based Compensation The Company has various stock-based compensation plans consisting of stock option grants and restricted share awards. Costs resulting from all share-based compensation plans are required to be recognized in the financial statements. A public entity is required to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. That cost is recognized over the required service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the required service.
Cash	Cash The Company defines “cash” as cash and time deposits with maturities of three months or less when purchased. Outstanding checks in excess of funds on deposit are included in accounts payable.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable Receivables are stated at amounts estimated by management to be the net realizable value. The Company charges off accounts receivable when it becomes apparent based upon age or customer circumstances that amounts will not be collected. Allowance for Doubtful Accounts The allowance for doubtful accounts is established through charges to the provision for bad debts. The Company evaluates the adequacy of the allowance for doubtful accounts on a periodic basis. The evaluation includes historical trends in collections and write-offs, management’s judgment of the probability of collecting accounts and management’s evaluation of business risk.
Inventory Valuation	Inventory Valuation Inventories are valued at the lower of average costs or market.
Goodwill	Goodwill Goodwill represents the excess of cost over fair value of net assets of businesses acquired. Goodwill is evaluated annually, as of October 1, for impairment or more frequently if an impairment indicator exists.
Intangible Assets and Other Long-Lived Assets	Intangible Assets and Other Long-Lived Assets Intangible assets are amortized over the expected useful life of the asset. Amortization expense directly attributed to the manufacturing of the Company’s products is included in cost of goods sold. Amortization expense related to non-manufacturing activities is included in selling and administrative and other. The Company evaluates the recoverability of intangible assets and other long-lived assets based on undiscounted projected cash flows, excluding interest and taxes, when factors indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment (“PP&E”) is carried at cost and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. In general, depreciation is computed using the straight-line method and recorded over the estimated useful life of the asset. Factory machinery and equipment is depreciated over periods ranging from 5 to 25 years with the majority of such assets (principally glass-melting furnaces and forming machines) depreciated over 7 to 15 years. Buildings and building equipment are depreciated over periods ranging from 10 to 50 years. Depreciation expense directly attributed to the manufacturing of the Company’s products is included in cost of goods sold. Depreciation expense related to non-manufacturing activities is included in selling and administrative. Depreciation expense includes the amortization of assets recorded under capital leases. Maintenance and repairs are expensed as incurred. Costs assigned to PP&E of acquired businesses are based on estimated fair values at the date of acquisition. The Company evaluates the recoverability of PP&E based on undiscounted projected cash flows, excluding interest and taxes, when factors indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
Derivative Instruments	Derivative Instruments The Company uses forward exchange contracts, options and commodity forward contracts to manage risks generally associated with foreign exchange rate and commodity market volatility. Derivative financial instruments are included on the balance sheet at fair value. When appropriate, derivative instruments are designated as and are effective as hedges, in accordance with accounting principles generally accepted in the United States. If the underlying hedged transaction ceases to exist, all changes in fair value of the related derivatives that have not been settled are recognized in current earnings. The Company does not enter into derivative financial instruments for trading purposes and is not a party to leveraged derivatives. Cash flows from forward exchange contracts not designated as hedges are classified as an investing activity. Cash flows of commodity forward contracts are classified as operating activities.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Generally accepted accounting principles defines a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to develop assumptions. The carrying amounts reported for cash and short-term loans approximate fair value. In addition, carrying amounts approximate fair value for certain long-term debt obligations subject to frequently redetermined interest rates. Fair values for the Company’s significant fixed rate debt obligations are generally based on published market quotations. The Company’s derivative assets and liabilities consist of natural gas forwards and foreign exchange option and forward contracts. The Company uses an income approach to valuing these contracts. Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates counterparty risk in determining fair values.
Reclassifications	Reclassifications Certain reclassifications of prior years’ data have been made to conform to the current year presentation.
New Accounting Standards	New Accounting Standards Revenue from Contracts with Customers - In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers," which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. In August 2015, the FASB issued ASU No. 2015-14, “Revenue from Contracts with Customers”, which delayed by one year the effective date of the new revenue recognition standard, which will be effective for the Company on January 1, 2018. The Company has started an implementation process, including a review of customer contracts, to evaluate the effect this standard will have on its consolidated financial statements and related disclosures. At this time, the Company does not expect that the implementation of this standard in 2018 will have a significant impact on the timing in which it recognizes revenue. While the Company continues to assess the potential impacts of the new standard, the Company does not currently expect the adoption of the new standard to have a material impact on consolidated net income or the consolidated balance sheet. The Company plans to select the modified retrospective transition method upon adoption effective January 1, 2018. Leases - In February 2016, the FASB issued ASU No. 2016-02, “Leases”. Under this guidance, lessees will be required to recognize on the balance sheet a lease liability and a right-of-use asset for all leases, with the exception of short-term leases. The lease liability represents the lessee's obligation to make lease payments arising from a lease, and will be measured as the present value of the lease payments. The right-of-use asset represents the lessee’s right to use a specified asset for the lease term, and will be measured at the lease liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs. The standard also requires a lessee to recognize a single lease cost allocated over the lease term, generally on a straight-line basis. The new guidance is effective for the Company on January 1, 2019. ASU No. 2016-02 is required to be applied using the modified retrospective approach for all leases existing as of the effective date and provides for certain practical expedients. Early adoption is permitted. The Company is currently evaluating the effects that the adoption of ASU No. 2016-02 will have on the Company’s consolidated financial statements, and anticipates the new guidance will significantly impact its consolidated financial statements as the Company has a significant number of leases. As further described in Note 16, Operating Leases, as of December 31, 2016, the Company had minimum lease commitments under non-cancellable operating leases totaling $205 million. Credit Losses - In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. This guidance also requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses. The new guidance is effective for the Company on January 1, 2020. Early adoption is permitted for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements. Stock Compensation - In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting,” which requires all excess tax benefits or deficiencies to be recognized as income tax expense or benefit in the income statement. In addition, excess tax benefits should be classified along with other income tax cash flows as an operating activity in the statement of cash flows. Application of the standard is required for the Company on January 1, 2017. The Company does not expect a significant impact in its Consolidated Financial Statements. Pension Asset Value - In May 2015, the FASB issued ASU No. 2015-07, “Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share (or Its Equivalent).” Under the new guidance, investments measured at net asset value (“NAV”), as a practical expedient for fair value, are excluded from the fair value hierarchy. Removing investments measured using the practical expedient from the fair value hierarchy is intended to eliminate the diversity in practice that currently exists with respect to the categorization of these investments. The new guidance is effective for the Company on January 1, 2016. The guidance impacted the presentation of certain pension related assets that use NAV as a practical expedient. See Note 9 for additional information.

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2016
Segment Information
Net sales for the Company's reportable segments	2016 2015 2014 Net sales: Europe $ $ $ North America Latin America Asia Pacific Reportable segment totals Other Net sales $ $ $
Segment operating profit (loss) for the Company's reportable segments	2016 2015 2014 Segment operating profit: Europe $ $ $ North America Latin America Asia Pacific Reportable segment totals Items excluded from segment operating profit: Retained corporate costs and other Charge for asbestos-related costs Restructuring, asset impairment and other charges Pension settlement charges Gain on China land sale Strategic transaction costs Acquisition-related fair value inventory adjustments Acquisition-related fair value intangible adjustments Non-income tax charge Interest expense, net Earnings from continuing operations before income taxes $ $ $
Total assets for the Company's reportable segments	Reportable Retained Consoli- North Latin Asia Segment Corp Costs dated Europe America America Pacific Totals and Other Totals Total assets: 2016 $ $ $ $ $ $ $ 2015 2014 Equity investments: 2016 $ $ $ — $ $ $ $ 2015 2014 Equity earnings: 2016 $ $ $ — $ $ $ $ 2015 2014 Capital expenditures: 2016 $ $ $ $ $ $ $ 2015 2014 Depreciation and amortization expense: 2016 $ $ $ $ $ $ $ 2015 2014
Schedule of segment information by geographic segment	The Company’s net property, plant and equipment by geographic segment are as follows: U.S. Non-U.S. Total 2016 $ $ $ 2015 2014 The Company’s net sales by geographic segment are as follows: U.S. Non-U.S. Total 2016 $ $ $ 2015 2014

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2016
Inventories
Major classes of inventory	2016 2015 Finished goods $ $ Raw materials Operating supplies $ $

Equity Investments (Tables)

Equity Investments (Tables)	12 Months Ended
	Dec. 31, 2016
Equity Investments
Company's ownership percentage in affiliates	At December 31, 2016 the Company’s ownership percentage in affiliates include: O-I Ownership Affiliates Percentage Business Type BJC O-I Glass Pte. Ltd. % Glass container manufacturer CO Vidrieria SARL ("COV") % Glass container manufacturer Rocky Mountain Bottle Company % Glass container manufacturer Tata Chemical (Soda Ash) Partners % Soda ash supplier Vetrerie Meridionali SpA ("VeMe") % Glass container manufacturer Vetri Speciali SpA % Specialty glass manufacturer
Equity in earnings	2016 2015 2014 Equity in earnings: Non-U.S. $ $ $ U.S. Total $ $ $ Dividends received $ $ $
Summary of balance sheet information of equity investments	2016 2015 At end of year: Current assets $ $ Non-current assets Total assets Current liabilities Other liabilities and deferred items Total liabilities and deferred items Net assets $ $
Summary of income statement information of equity investments	For the year: 2016 2015 2014 Net sales $ $ $ Gross profit $ $ $ Net earnings $ $ $

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets
Schedule of changes in carrying amount of goodwill	North Latin Europe America America Other Total Balance as of January 1, 2014 $ $ $ $ $ Translation effects Balance as of December 31, 2014 Acquisition related adjustments Translation effects Balance as of December 31, 2015 Acquisition related adjustments Translation effects Balance as of December 31, 2016 $ $ $ $ $

Prepaid Expenses and Other As37

Prepaid Expenses and Other Assets (Tables)	12 Months Ended
	Dec. 31, 2016
Prepaid Expenses and Other Assets
Schedule of Prepaid expenses and other current assets	2016 2015 Prepaid expenses $ $ Value added taxes Other $ $
Schedule of other assets (noncurrent)	2016 2015 Deferred tax assets $ $ Deferred returnable packaging costs Repair part inventories Capitalized software Value added taxes Deferred finance fees Other $ $

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
	Dec. 31, 2016
Derivative Instruments
Effect of commodity futures contracts designated as cash flow hedges on the results of operations	Amount of gain (loss) Reclassified from Amount of gain (loss) Recognized in OCI on Accumulated OCI into Income Commodity Forward Contracts (reported in cost of goods sold) (Effective Portion) (Effective Portion) 2016 2015 2014 2016 2015 2014 $ $ $ $ — $ (1) $ 2
Effect of the foreign exchange contracts not designated as hedging instruments on the results of operations	Amount of Gain (Loss) Location of Gain (Loss) Recognized in Income on Recognized in Income on Foreign Exchange Contracts Foreign Exchange Contracts 2016 2015 2014 Other expense, net $ $ $
Balance Sheet Classification of derivative instruments	Fair Value Balance Sheet Location 2016 2015 Asset Derivatives: Derivatives designated as hedging instruments: Commodity futures contracts b $ $ — Derivatives not designated as hedging instruments: Foreign exchange derivative contracts a $ $ Total asset derivatives $ $ Liability Derivatives: Derivatives designated as hedging instruments: Commodity futures contracts c $ — $ Derivatives not designated as hedging instruments: Foreign exchange derivative contracts c Total liability derivatives $ $

Restructuring Accruals, Asset39

Restructuring Accruals, Asset Impairments and Other Costs Related to Closed Facilities (Tables)	12 Months Ended
	Dec. 31, 2016
Restructuring Accruals, Asset Impairments and Other Costs Related to Closed Facilities
Selected information related to the restructuring accruals	The following table presents information related to restructuring, asset impairment and other costs related to closed facilities from January 1, 2015 through December 31, 2015: European Other Asset Asia Pacific Restructuring Total Optimization Restructuring Actions Restructuring Balance at January 1, 2015 $ $ $ $ Charges Write-down of assets to net realizable value Net cash paid, principally severance and related benefits Other, including foreign exchange translation Balance at December 31, 2015 $ $ $ $ The following table presents information related to restructuring, asset impairment and other costs related to closed facilities from January 1, 2016 through December 31, 2016: Other Asia Pacific Restructuring Total Restructuring Actions Restructuring Balance at January 1, 2016 $ $ $ Charges Write-down of assets to net realizable value Net cash paid, principally severance and related benefits Other, including foreign exchange translation Balance at December 31, 2016 $ $ $

Pension Benefit Plans and Oth40

Pension Benefit Plans and Other Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2016
Pension Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans
Changes in the benefit obligations	U.S. Non-U.S. 2016 2015 2016 2015 Obligations at beginning of year $ $ $ $ Change in benefit obligations: Service cost Interest cost Actuarial (gain) loss, including the effect of change in discount rates Curtailment, settlement, and plan amendment Acquisitions Participant contributions Benefit payments Other Foreign currency translation Net change in benefit obligations Obligations at end of year $ $ $ $
Changes in the fair value of the pension plans' assets	U.S. Non-U.S. 2016 2015 2016 2015 Fair value at beginning of year $ $ $ $ Change in fair value: Actual gain (loss) on plan assets Benefit payments Employer contributions Participant contributions Settlements Acquisitions Foreign currency translation Other Net change in fair value of assets Fair value at end of year $ $ $ $
Funded status	U.S. Non-U.S. 2016 2015 2016 2015 Plan assets at fair value $ $ $ $ Projected benefit obligations Plan assets less than projected benefit obligations Items not yet recognized in pension expense: Actuarial loss Prior service cost (credit) Net amount recognized $ $ $ $
Net amount recognized included in the Consolidated Balance Sheets	U.S. Non-U.S. 2016 2015 2016 2015 Pension assets $ — $ — $ $ Current pension liability, included with other accrued liabilities Pension benefits Accumulated other comprehensive loss Net amount recognized $ $ $ $
Changes in plan assets and/or benefit obligations recognized in accumulated other comprehensive income	U.S. Non-U.S. 2016 2015 2016 2015 Current year actuarial (gain) loss $ $ $ $ Amortization of actuarial loss Settlement — Translation $ $ $ $
Components of net periodic pension cost (income) and net periodic postretirement (benefit) cost	U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Service cost $ $ $ $ $ $ Interest cost Expected asset return Amortization: Actuarial loss Prior service credit Net amortization Net expense $ $ $ $ $ $
Amounts amortized from accumulated other comprehensive income during 2015	U.S. Non-U.S. Amortization: Actuarial loss $ $ Prior service cost Net amortization $ $
Information for plans with projected and accumulated benefit obligations in excess of the fair value of plan assets	Projected Benefit Obligation Exceeds Accumulated Benefit Obligation Exceeds the Fair Value of Plan Assets the Fair Value of Plan Assets U.S. Non-U.S. U.S. Non-U.S. 2016 2015 2016 2015 2016 2015 2016 2015 Projected benefit obligations $ 1,956 $ $ $ $ 1,956 $ $ 897 $ Accumulated benefit obligation 1,956 1,956 867 Fair value of plan assets 1,654 1,654 632
Weighted average assumptions used to determine benefit obligations and net periodic pension costs for pension plans, and accumulated postretirement benefit obligation and net postretirement benefit cost for postretirement plans	The weighted average assumptions used to determine benefit obligations are as follows: U.S. Non-U.S. 2016 2015 2016 2015 Discount rate % % % % Rate of compensation increase N/A % % % The weighted average assumptions used to determine net periodic pension costs are as follows: U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Discount rate 4.43 % % % 3.68 % % % Rate of compensation increase 2.97 % % % 2.84 % % % Expected long-term rate of return on assets 7.50 % % % 7.15 % % %
Fair value of defined benefit pension plan assets and target allocations	2016 2015 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash and cash equivalents $ $ — $ — $ $ $ — $ — $ Equity securities — — Debt securities Real estate Other Total $ $ $ $ $ $ Investments measured at net asset value $ $ Total non-U.S. assets at fair value $ $
Reconciliation of pension plan assets recorded at fair value using significant unobservable inputs (Level 3)	2016 2015 Beginning balance $ $ Net increase (decrease) Ending balance $ $
Estimated future benefit payments, reflecting expected future service, as appropriate, expected to be paid	Year(s) U.S. Non-U.S. 2017 $ $ 2018 2019 2020 2021 2022-2026
Postretirement Benefits Other Than Pensions
Defined Benefit Plans and Other Postretirement Benefit Plans
Changes in the benefit obligations	U.S. Non-U.S. 2016 2015 2016 2015 Obligations at beginning of year $ $ $ $ Change in benefit obligations: Service cost Interest cost Actuarial (gain) loss, including the effect of changing discount rates Benefit payments Foreign currency translation Other Net change in benefit obligations Obligations at end of year $ $ $ $
Funded status	U.S. Non-U.S. 2016 2015 2016 2015 Postretirement benefit obligations $ $ $ $ Items not yet recognized in net postretirement benefit cost: Actuarial gain (loss) Prior service credit Net amount recognized $ $ $ $
Net amount recognized included in the Consolidated Balance Sheets	U.S. Non-U.S. 2016 2015 2016 2015 Current nonpension postretirement benefit, included with Other accrued liabilities $ $ $ $ Nonpension postretirement benefits Accumulated other comprehensive income (loss) Net amount recognized $ $ $ $
Changes in plan assets and/or benefit obligations recognized in accumulated other comprehensive income	U.S. Non-U.S. 2016 2015 2016 2015 Current year actuarial (gain) loss $ $ $ $ — Amortization of actuarial loss Amortization of prior service credit $ $ $ $ —
Components of net periodic pension cost (income) and net periodic postretirement (benefit) cost	U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Service cost $ — $ — $ — $ $ $ Interest cost Curtailment gain Amortization: Actuarial loss Prior service credit Net amortization — — — Net postretirement benefit (income) cost $ $ $ $ $ $
Amounts amortized from accumulated other comprehensive income during 2015	U.S. Non-U.S. Amortization: Actuarial loss $ $ — Prior service credit Net amortization $ $ —
Weighted average assumptions used to determine benefit obligations and net periodic pension costs for pension plans, and accumulated postretirement benefit obligation and net postretirement benefit cost for postretirement plans	U.S. Non-U.S. 2016 2015 2014 2016 2015 2014 Accumulated postretirement benefit obligation % % % % % % Net postretirement benefit cost % % % % % %
Estimated future benefit payments, reflecting expected future service, as appropriate, expected to be paid	Year(s) U.S. Non-U.S. 2017 $ $ 2018 2019 2020 2021 2022 - 2026
Weighted average assumed health care cost trend rates	U.S. Non-U.S. 2016 2015 2016 2015 Health care cost trend rate assumed for next year % % % % Rate to which the cost trend rate is assumed to decline (ultimate trend rate) % % % % Year that the rate reaches the ultimate trend rate N/A N/A
Effects of one-percentage-point change in assumed health care cost trend rates on amount reported for the postretirement benefit plans	U.S. Non-U.S. 1-Percentage-Point 1-Percentage-Point Increase Decrease Increase Decrease Effect on total of service and interest cost $ — $ — $ $ Effect on accumulated postretirement benefit obligations

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Income Taxes
Provision (benefit) for income taxes calculated based on components of earnings (loss) before income taxes	Continuing operations 2016 2015 2014 U.S. $ $ — $ Non-U.S. $ $ $ Discontinued operations 2016 2015 2014 U.S. $ — $ — $ Non-U.S. $ $ $
Provision (benefit) for income taxes	2016 2015 2014 Current: U.S. $ — $ $ Non-U.S. Deferred: U.S. — Non-U.S. Total: U.S. Non-U.S. Total for continuing operations Total for discontinued operations — — — $ $ $
Reconciliation of the provision for income taxes	2016 2015 2014 Tax provision on pretax earnings from continuing operations at statutory U.S. Federal tax rate $ $ $ Increase (decrease) in provision for income taxes due to: Non-U.S. tax rates Changes in valuation allowance Withholding tax, net Non-deductible acquisition costs U.S. tax on intercompany dividends and interest Tax exempt income Intraperiod tax allocation Tax law changes Tax credit Changes in tax reserves Mexico inflationary adjustments Other items Provision for income taxes $ $ $
Significant components of deferred tax assets and liabilities and deferred taxes included in the Consolidated Balance Sheets	2016 2015 Deferred tax assets: Accrued postretirement benefits $ $ Asbestos-related liabilities Foreign tax credit Operating and capital loss carryovers Other credit carryovers Accrued liabilities Pension liability Other Total deferred tax assets Deferred tax liabilities: Property, plant and equipment Intangibles and deferred software Other Total deferred tax liabilities Valuation allowance Net deferred taxes $ $ Deferred taxes are included in the Consolidated Balance Sheets at December 31, 2016 and 2015 as follows: 2016 2015 Other assets $ $ Deferred taxes Net deferred taxes $ $
Reconciliation of the gross unrecognized tax benefits	2016 2015 2014 Balance at January 1 $ $ $ Additions and reductions for tax positions of prior years Additions based on tax positions related to the current year Reductions due to the lapse of the applicable statute of limitations Reductions due to settlements Foreign currency translation Balance at December 31 $ $ $ Unrecognized tax benefits, which if recognized, would impact the Company’s effective income tax rate $ $ $ Accrued interest and penalties at December 31 $ $ $ Interest and penalties included in tax expense for the years ended December 31 $ $ $

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2016
Debt
Long-term Debt	2016 2015 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ — $ — Term Loans: Term Loan A Term Loan A (€279 million at December 31, 2016) Term Loan B Senior Notes: 6.75%, due 2020 (€500 million) 4.875%, due 2021 (€330 million) 5.00%, due 2022 5.875%, due 2023 3.125%, due 2024 (€500 million) 5.375%, due 2025 6.375%, due 2025 Senior Debentures: 7.80%, due 2018 Capital leases Other Total long-term debt Less amounts due within one year Long-term debt $ $
Information related to accounts receivable securitization program	2016 2015 Balance (included in short-term loans) $ $ Weighted average interest rate % %
Fair values of the Company's significant fixed rate debt obligations	Principal Indicated Amount Market Price Fair Value Senior Notes: 6.75%, due 2020 (€500 million) $ $ $ 4.875%, due 2021 (€330 million) 5.00%, due 2022 5.875%, due 2023 3.125%, due 2024 (€500 million) 6.375%, due 2025 5.375%, due 2025 Senior Debentures: 7.80%, due 2018

Contingencies (Tables)

Contingencies (Tables)	12 Months Ended
	Dec. 31, 2016
Contingencies
Asbestos filings and the claims pending at the end of each listed year	2016 2015 2014 Pending at beginning of year Disposed Filed Pending at end of year

Accumulated Other Comprehensi44

Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2016
Accumulated Other Comprehensive Income (Loss)
Component of accumulated other comprehensive loss	Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Income (Loss) Balance on January 1, 2015 $ $ $ $ Change before reclassifications Amounts reclassified from accumulated other comprehensive income (a) (b) Translation effect Tax effect Other comprehensive income (loss) attributable to the Company Balance on December 31, 2015 Change before reclassifications Amounts reclassified from accumulated other comprehensive income (a) (b) Translation effect Tax effect Intraperiod tax allocation Other comprehensive income (loss) attributable to the Company Balance on December 31, 2016 $ $ $ $ (a) Amount is included in Cost of goods sold on the Consolidated Results of Operations (see Note 7 for additional information). Amount is included in the computation of net periodic pension cost and net postretirement benefit cost (see Note 9 for additional information).

Stock Options and Other Stock45

Stock Options and Other Stock Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2016
Stock Options and Other Stock Based Compensation
Summary of option activity	Weighted Weighted Average Average Remaining Number of Exercise Contractual Aggregate Shares Price Term Intrinsic (thousands) (per share) (years) Value Options outstanding at January 1, 2016 $ Granted Exercised Forfeited or expired Options outstanding at December 31, 2016 $ Options vested or expected to vest at December 31, 2016 $ $ Options exercisable at December 31, 2016 $ $ —
Additional information related to stock options	2016 2015 2014 Weighted average grant-date fair value of options granted (per share) $ $ $ Aggregate intrinsic value of options exercised $ $ — $ Aggregate cash received from options exercised $ $ $
Schedule of weighted average assumptions used to estimate the fair value of each option grant on the date of grant using the Black-Scholes option pricing model	2016 2015 2014 Expected life of options (years) Expected stock price volatility % % % Risk-free interest rate % % % Expected dividend yield % % %
Restricted shares and restricted share units activity	Weighted Number of Average Restricted Grant-Date Shares Fair Value (thousands) (per share) Nonvested at January 1, 2016 $ Granted Vested Forfeited Nonvested at December 31, 2016 Awards granted during 2015 $ Awards granted during 2014 $ 2016 2015 2014 Total fair value of shares vested $ $ $
Performance vested restricted share unit activity	Number of Performance Weighted Average Vested Restricted Shares Grant-Date Fair Value Units (thousands) (per unit) Nonvested at January 1, 2016 $ Granted Vested Forfeited/Cancelled Nonvested at December 31, 2016 Awards granted during 2015 $ Awards granted during 2014 $

Other Expense, net (Tables)

Other Expense, net (Tables)	12 Months Ended
	Dec. 31, 2016
Other Expense, net
Schedule of other expense (income), net	2016 2015 2014 Restructuring, asset impairment and other charges $ $ $ Intangible amortization expense Impairment of equity investment Charge for asbestos related costs Gain on China land compensation Royalty income Strategic transaction costs Acquisition-related fair value intangible adjustments Non-income tax charge Foreign currency exchange loss (gain) Other expense (income) $ $ $

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2016
Earnings Per Share
Computation of basic and diluted earnings per share	2016 2015 2014 Numerator: Net earnings attributable to the Company $ $ $ Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding Effect of dilutive securities: Stock options and other Denominator for diluted earnings per share-adjusted weighted average shares outstanding Basic earnings per share: Earnings from continuing operations $ $ $ Loss from discontinued operations Net earnings $ $ $ Diluted earnings per share: Earnings from continuing operations $ $ $ Loss from discontinued operations Net earnings $ $ $

Supplemental Cash Flow Inform48

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2016
Supplemental Cash Flow Information
Supplemental cash flow information	2016 2015 2014 Decrease (increase) in current assets: Receivables $ $ $ Inventories Prepaid expenses and other Increase (decrease) in current liabilities: Accounts payable Accrued liabilities Salaries and wages U.S. and foreign income taxes $ $ $
Income taxes paid (received) in cash	2016 2015 2014 Interest paid in cash $ $ $ Income taxes paid in cash (all non-U.S)

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
	Dec. 31, 2016
Business Combinations
Schedule of preliminary estimates of fair value of the assets and liabilities	September 1, 2015 Measurement Period Adjustments September 30, 2016 Cash $ $ — $ Other current assets Goodwill Customer list intangibles Net property, plant and equipment Total assets Current liabilities Long-term debt Long-term liabilities Net assets acquired $ $ — $

Pro Forma Information - Vitro50

Pro Forma Information - Vitro Acquisition (Tables)	12 Months Ended
	Dec. 31, 2016
Pro Forma Information – Vitro Acquisition
Schedule of pro-forma information	Year Ending December 31, 2015 As Acquisition Financing Pro Forma Reported Adjustments Adjustments As Adjusted Net sales $ $ $ — $ Earnings from continuing operations attributable to the Company $ $ $ $ Diluted earnings per share from continuing operations $ $

Financial Information for Sub51

Financial Information for Subsidiary Guarantors and Non-Guarantors (Tables)	12 Months Ended
	Dec. 31, 2016
Financial Information for Subsidiary Guarantors and Non-Guarantors Disclosure
Balance Sheet	December 31, 2016 Guarantor Non-Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ $ — $ Trade receivables, net Inventories Prepaid expenses and other current assets Total current assets — — — Investments in and advances to subsidiaries — Property, plant and equipment, net Intangibles Goodwill Other assets Total assets $ $ $ $ $ Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ $ — $ Current portion of asbestos liability Accounts payable Other liabilities Total current liabilities — Long-term debt Asbestos-related liabilities Other long-term liabilities Share owners’ equity Noncontrolling interests Total liabilities and share owners’ equity $ $ $ $ $ December 31, 2015 Non- Guarantor Guarantor Balance Sheet Parent Subsidiaries Subsidiaries Eliminations Consolidated Current assets: Cash and cash equivalents $ — $ — $ $ — $ Trade receivables, net Inventories Prepaid expenses and other current assets Total current assets — — — Investments in and advances to subsidiaries — Property, plant and equipment, net Intangibles Goodwill Other assets Total assets $ $ $ $ $ Current liabilities : Short-term loans and long-term debt due within one year $ — $ — $ $ — $ Current portion of asbestos liability Accounts payable Other liabilities Total current liabilities — Long-term debt Asbestos-related liabilities Other long-term liabilities Share owners’ equity Noncontrolling interests Total liabilities and share owners’ equity $ $ $ $ $
Results of Operations and Comprehensive Income	Year ended December 31, 2016 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ $ $ $ $ Cost of goods sold Gross profit Selling and administrative expense Research, development and engineering expense Net intercompany interest — Interest expense, net Equity earnings from subsidiaries — — Other equity earnings Other expense, net Earnings before income taxes Provision for income taxes Earnings from continuing operations Loss from discontinued operations Net earnings Net earnings attributable to noncontrolling interests Net earnings attributable to the Company $ $ $ $ $ Year ended December 31, 2016 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ $ $ $ $ Other comprehensive income (loss) Total comprehensive income (loss) Comprehensive income attributable to noncontrolling interests Comprehensive income (loss) attributable to the Company $ $ $ $ $ Year ended December 31, 2015 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ $ — $ Cost of goods sold Gross profit Selling and administrative expense Research, development and engineering expense Net intercompany interest — Interest expense, net Equity earnings from subsidiaries — Other equity earnings Other expense, net Earnings before income taxes Provision for income taxes Earnings from continuing operations Loss from discontinued operations Net earnings Net earnings attributable to noncontrolling interests Net earnings attributable to the Company $ $ $ $ $ Year ended December 31, 2015 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ $ $ $ $ Other comprehensive income (loss) Total comprehensive income (loss) Comprehensive income attributable to noncontrolling interests Comprehensive income (loss) attributable to the Company $ $ $ $ $ Year ended December 31, 2014 Non- Guarantor Guarantor Results of Operations Parent Subsidiaries Subsidiaries Eliminations Consolidated Net sales $ — $ — $ $ — $ Cost of goods sold Gross profit Selling and administrative expense Research, development and engineering expense Net intercompany interest — Interest expense, net Equity earnings from subsidiaries — Other equity earnings Other expense, net Earnings before income taxes Provision for income taxes Earnings from continuing operations Loss from discontinued operations Net earnings Net earnings attributable to noncontrolling interests Net earnings attributable to the Company $ $ $ $ $ Year ended December 31, 2014 Non- Guarantor Guarantor Comprehensive Income Parent Subsidiaries Subsidiaries Eliminations Consolidated Net earnings $ $ $ $ $ Other comprehensive income (loss) Total comprehensive income (loss) Comprehensive income attributable to noncontrolling interests Comprehensive income (loss) attributable to the Company $ $ $ $ $
Cash Flows	Year ended December 31, 2016 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ $ — $ $ — $ Cash utilized in investing activities Cash provided by (utilized in) financing activities Effect of exchange rate change on cash Net change in cash — — — Cash at beginning of period Cash at end of period $ — $ — $ $ — $ Year ended December 31, 2015 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ $ — $ $ — $ Cash utilized in investing activities Cash provided by financing activities Effect of exchange rate change on cash Net change in cash — — — Cash at beginning of period Cash at end of period $ — $ — $ $ — $ Year ended December 31, 2014 Non- Guarantor Guarantor Cash Flows Parent Subsidiaries Subsidiaries Eliminations Consolidated Cash provided by (utilized in) operating activities $ $ — $ $ — $ Cash utilized in investing activities Cash provided by (utilized in) financing activities Effect of exchange rate change on cash Net change in cash — — — Cash at beginning of period Cash at end of period $ — $ — $ $ — $

Significant Accounting Polici52

Significant Accounting Policies - Equity Method Investments and Stock-Based Compensation (Details)	Dec. 31, 2016item
Equity Method Investments
Number of countries in which the entity operates	23
Maximum
Equity Method Investments
General ownership percentage for equity method investments	50.00%
Minimum
Equity Method Investments
General ownership percentage for equity method investments	20.00%

Significant Accounting Polici53

Significant Accounting Policies - PPE (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)
New Accounting Standards
Minimum lease commitments under non cancellable operating leases	$ 205
Factory machinery and equipment | Minimum
Property, Plant and Equipment
Estimated useful lives	5 years
Factory machinery and equipment | Maximum
Property, Plant and Equipment
Estimated useful lives	25 years
Glass-melting furnaces and forming machines | Minimum
Property, Plant and Equipment
Estimated useful lives	7 years
Glass-melting furnaces and forming machines | Maximum
Property, Plant and Equipment
Estimated useful lives	15 years
Buildings and building equipment | Minimum
Property, Plant and Equipment
Estimated useful lives	10 years
Buildings and building equipment | Maximum
Property, Plant and Equipment
Estimated useful lives	50 years

Segment Information - Reportabl

Segment Information - Reportable Segments (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)segmentregion	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Segment Reporting Information
Number of reportable segments | segment	4
Regions not directly related to operations | region	1
Net sales:
Net sales	$ 6,702	$ 6,156	$ 6,784
Items excluded from Segment Operating Profit:
Retained corporate costs and other	(98)	(70)	(100)
Charge for asbestos-related costs		(16)	(46)
Restructuring, asset impairment and other	(129)	(80)	(91)
Pension settlement charges	(98)		(65)
Gain on China land sale	71
Strategic transaction costs		(23)
Acquisition-related fair value inventory adjustments		(22)
Acquisition-related fair value intangible adjustments		(10)
Non-income tax charge			(69)
Interest expense, net
Interest expense, net	(272)	(251)	(230)
Earnings from continuing operations before income taxes
Earnings from continuing operations before income taxes	356	268	307
Reportable Segment Totals
Net sales:
Net sales	6,636	6,098	6,749
Segment operating profit:
Segment operating profit	882	740	908
Europe
Net sales:
Net sales	2,300	2,324	2,794
Segment operating profit:
Segment operating profit	237	209	353
North America
Net sales:
Net sales	2,220	2,039	2,003
Segment operating profit:
Segment operating profit	299	265	240
Latin America
Net sales:
Net sales	1,432	1,064	1,159
Segment operating profit:
Segment operating profit	269	183	227
Asia Pacific
Net sales:
Net sales	684	671	793
Segment operating profit:
Segment operating profit	77	83	88
Other.
Net sales:
Net sales	$ 66	$ 58	$ 35

Segment Information - Assets, I

Segment Information - Assets, Investments, Equity, Capital Expenses and Depreciation and Amortization (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Assets
Total assets:	$ 9,135	$ 9,421	$ 7,843
Equity investments
Equity investments:	433	409	427
Equity earnings:
Equity earnings	60	60	64
Capital expenditures:
Capital expenditures:	454	402	369
Depreciation and amortization expense:
Depreciation and amortization expense:	478	409	418
Reportable Segment Totals
Assets
Total assets:	8,777	9,126	7,503
Equity investments
Equity investments:	216	245	258
Equity earnings:
Equity earnings	31	42	40
Capital expenditures:
Capital expenditures:	453	400	366
Depreciation and amortization expense:
Depreciation and amortization expense:	467	395	403
Europe
Assets
Total assets:	2,792	2,902	3,214
Equity investments
Equity investments:	78	78	81
Equity earnings:
Equity earnings	15	16	19
Capital expenditures:
Capital expenditures:	163	164	188
Depreciation and amortization expense:
Depreciation and amortization expense:	118	120	140
North America
Assets
Total assets:	2,522	2,500	1,971
Equity investments
Equity investments:	21	22	24
Equity earnings:
Equity earnings	12	19	17
Capital expenditures:
Capital expenditures:	108	97	89
Depreciation and amortization expense:
Depreciation and amortization expense:	139	128	131
Latin America
Assets
Total assets:	2,537	2,807	1,300
Capital expenditures:
Capital expenditures:	123	89	55
Depreciation and amortization expense:
Depreciation and amortization expense:	173	107	79
Asia Pacific
Assets
Total assets:	926	917	1,018
Equity investments
Equity investments:	117	145	153
Equity earnings:
Equity earnings	4	7	4
Capital expenditures:
Capital expenditures:	59	50	34
Depreciation and amortization expense:
Depreciation and amortization expense:	37	40	53
Other.
Assets
Total assets:	358	295	340
Equity investments
Equity investments:	217	164	169
Equity earnings:
Equity earnings	29	18	24
Capital expenditures:
Capital expenditures:	1	2	3
Depreciation and amortization expense:
Depreciation and amortization expense:	$ 11	$ 14	$ 15

Segment Information - PPE and G

Segment Information - PPE and Geographical Sales (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information
Property, plant and equipment, net	$ 2,880	$ 2,961	$ 2,445
Net sales	6,702	6,156	6,784
Latin America
Segment Reporting Information
Net sales	1,432	1,064	1,159
Latin America | Intercompany sales
Segment Reporting Information
Net sales	195	101	0
U.S.
Segment Reporting Information
Property, plant and equipment, net	749	736	713
Net sales	2,124	1,939	1,852
Non-U.S.
Segment Reporting Information
Property, plant and equipment, net	2,131	2,225	1,732
Net sales	$ 4,578	$ 4,217	$ 4,932

Segment Information - Concentra

Segment Information - Concentration by Geography (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Minimum
Segment Reporting Information
Percentage of consolidated net sales from continuing operations (as a percent)	10.00%
France
Segment Reporting Information
Percentage of consolidated net sales from continuing operations (as a percent)		10.00%	11.00%

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Inventories
Finished goods	$ 827	$ 858
Raw materials	118	113
Operating supplies	38	36
Inventories	$ 983	$ 1,007

Equity Investments (Details)

Equity Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Equity Investments Information
Equity earnings	$ 60	$ 60	$ 64
Summarized combined financial information for equity associates at end of year:
Current assets	451	430
Non-current assets	1,025	959
Total assets	1,476	1,389
Current liabilities	200	203
Other liabilities and deferred items	368	211
Total liabilities and deferred items	568	414
Net assets	908	975
Summarized combined financial information for equity associates for the year:
Net sales	755	719	752
Gross profit	182	193	198
Net earnings	134	139	150
Dividends received	38	53	54
Difference between investment carrying value and amount of underlying equity in net assets	12
Purchased equity from affiliates	176	161
Due to Affiliate	76	66
Non-U.S.
Equity Investments Information
Equity earnings	19	23	23
U.S.
Equity Investments Information
Equity earnings	$ 41	$ 37	$ 41
BJC O-I Glass Pte. Ltd
Equity Investments Information
Percentage of equity method investments	50.00%
CO Vidrieria SARL ("COV")
Equity Investments Information
Percentage of equity method investments	50.00%
Rocky Mountain Bottle Company
Equity Investments Information
Percentage of equity method investments	50.00%
Tata Chemical (Soda Ash) Partners
Equity Investments Information
Percentage of equity method investments	25.00%
Vetrerie Meridionali SpA
Equity Investments Information
Percentage of equity method investments	50.00%
Vetri Speciali SpA
Equity Investments Information
Percentage of equity method investments	50.00%

Goodwill - Goodwill Rollforward

Goodwill - Goodwill Rollforward (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Changes in the carrying amount of goodwill
Balance of Goodwill at beginning of period		$ 2,489	$ 1,893	$ 2,059
Acquisitions		41	796
Translation effects		(68)	(200)	(166)
Balance of Goodwill at end of the period	$ 2,462	2,462	2,489	1,893
Impairment charge	0
Europe
Changes in the carrying amount of goodwill
Balance of Goodwill at beginning of period		840	926	1,044
Translation effects		(32)	(86)	(118)
Balance of Goodwill at end of the period	808	808	840	926
North America
Changes in the carrying amount of goodwill
Balance of Goodwill at beginning of period		1,020	723	734
Acquisitions		15	316
Translation effects		3	(19)	(11)
Balance of Goodwill at end of the period	1,038	1,038	1,020	723
Latin America
Changes in the carrying amount of goodwill
Balance of Goodwill at beginning of period		624	239	276
Acquisitions		26	480
Translation effects		(39)	(95)	(37)
Balance of Goodwill at end of the period	611	611	624	239
Other.
Changes in the carrying amount of goodwill
Balance of Goodwill at beginning of period		5	5	5
Balance of Goodwill at end of the period	5	5	5	5
Asia Pacific
Changes in the carrying amount of goodwill
Balance of Goodwill at beginning of period		0	0
Balance of Goodwill at end of the period	0	0	0	0
Accumulated impairment losses	$ 1,135	$ 1,135	$ 1,135	$ 1,135

Goodwill - Schedule of Intangib

Goodwill - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets
Net Carrying Amount	$ 464	$ 597
Customer list intangibles
Finite-Lived Intangible Assets
Useful life	20 years
Amortization expense	$ 39	$ 21	$ 1
2,017	44
2,018	44
2,019	42
2,020	41
2,021	39
Impairment of intangible assets	$ 0

Prepaid Expenses and Other As62

Prepaid Expenses and Other Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Prepaid expenses and other current assets:
Prepaid expenses	$ 50	$ 52
Value added taxes	46	195
Other	103	119
Prepaid expenses and other current assets	199	366
Other assets (non current):
Deferred tax asset	185	177
Deferred returnable packaging costs	115	110
Repair parts inventories	107	118
Capitalized software	85	86
Value added taxes	22	17
Deferred finance fees	5	6
Other	83	85
Total other assets	602	599
Capitalized software
Other information related to capitalized software
Amortization expense for capitalized software	13	$ 19	$ 17
Estimated amortization expense
2,017	14
2,018	14
2,019	13
2,020	12
2,021	$ 11

Derivative Instruments - Deriva

Derivative Instruments - Derivatives and Hedges (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)MMBTU	Dec. 31, 2015USD ($)MMBTU	Dec. 31, 2014USD ($)
Derivatives and Hedges
Foreign exchange contracts gain (loss) recognized in income	$ 6	$ 10	$ (8)
Commodity forward contracts | Cash Flow Hedges
Derivatives and Hedges
Coverage of commodity forward contracts (in MM BTUs) | MMBTU	12,300,000	7,300,000
Unrecognized (loss) gain included in Accumulated OCI	$ 6	$ (4)
Commodity forward contracts gain (loss) recognized in OCI	$ 7	(4)	3
Commodity forward contracts gain (loss) reclassified from accumulated OCI into income		(1)	$ 2
Commodity forward contracts | Cash Flow Hedges | Minimum
Derivatives and Hedges
Period during which unrecognized loss included in Accumulated OCI will be reclassified into earnings	12 months
Commodity forward contracts | Cash Flow Hedges | Maximum
Derivatives and Hedges
Period during which unrecognized loss included in Accumulated OCI will be reclassified into earnings	24 months
Forward exchange contracts | Derivatives not designated as hedging instruments
Derivatives and Hedges
Foreign exchange contracts in various currencies	$ 490	$ 790

Derivative Instruments - Balanc

Derivative Instruments - Balance Sheet Classification (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Derivatives, Fair Value
Total asset derivatives	$ 15	$ 14
Total liability derivatives	5	5
Derivatives not designated as hedging instruments | Foreign exchange derivative contracts | Receivables.
Derivatives, Fair Value
Total asset derivatives	9	14
Derivatives not designated as hedging instruments | Foreign exchange derivative contracts | Other accrued liabilities or other liabilities (current)
Derivatives, Fair Value
Total liability derivatives	5	2
Derivatives designated as hedging instruments | Commodity forward contracts | Receivables.
Derivatives, Fair Value
Total asset derivatives	$ 6
Derivatives designated as hedging instruments | Commodity futures contracts | Other accrued liabilities or other liabilities (current)
Derivatives, Fair Value
Total liability derivatives		$ 3

Restructuring Accruals, Asset65

Restructuring Accruals, Asset Impairments and Other Costs Related to Closed Facilities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Restructuring accrual
Beginning balance, restructuring reserve	$ 43	$ 60
Charges	98	63	$ 76
Write-down of assets to net realizable value	(28)	(31)
Net cash paid, principally severance and related benefits	(24)	(38)	(58)
Other, including foreign exchange translation	(4)	(11)
Ending balance, restructuring reserve	85	43	60
European Asset Optimization
Restructuring accrual
Beginning balance, restructuring reserve	3	12
Net cash paid, principally severance and related benefits		(5)
Other, including foreign exchange translation		(4)
Ending balance, restructuring reserve		3	12
Restructuring, Additional Information
Cumulative employee costs and asset impairments	127
Employee costs and asset impairments	0	0	1
Asia Pacific Restructuring
Restructuring accrual
Beginning balance, restructuring reserve	7	12
Charges	4	5
Write-down of assets to net realizable value		(4)
Net cash paid, principally severance and related benefits	(3)	(5)
Other, including foreign exchange translation	(1)	(1)
Ending balance, restructuring reserve	7	7	12
Restructuring, Additional Information
Cumulative employee costs and asset impairments	224
Employee costs and asset impairments	4	5	73
Other Restructuring Actions
Restructuring accrual
Beginning balance, restructuring reserve	33	36
Charges	94	58
Write-down of assets to net realizable value		(27)
Net cash paid, principally severance and related benefits		(28)
Other, including foreign exchange translation		(6)
Ending balance, restructuring reserve		33	36
Restructuring, Additional Information
Miscellaneous other costs	30	6
Headcount reduction charges			$ 2
Other Restructuring Actions | Latin America
Restructuring, Additional Information
Employee costs and asset impairments		14
Employee costs, asset impairments and other exit costs	64
Other Restructuring Actions
Restructuring accrual
Beginning balance, restructuring reserve	36
Charges	94
Write-down of assets to net realizable value	(28)
Net cash paid, principally severance and related benefits	(21)
Other, including foreign exchange translation	(3)
Ending balance, restructuring reserve	78	36
Other
Restructuring, Additional Information
Employee costs and asset impairments		58
North America | Other Restructuring Actions
Restructuring, Additional Information
Employee costs and asset impairments		$ 38
Severance and other employee separation costs
Restructuring, Additional Information
Estimated amount of restructuring accrual balance	67
Environmental remediation costs
Restructuring, Additional Information
Estimated amount of restructuring accrual balance	16
Other exit costs
Restructuring, Additional Information
Estimated amount of restructuring accrual balance	$ 2

Pensions Benefit Plans and Othe

Pensions Benefit Plans and Other Postretirement Benefits - Changes in the Benefit Obligation (Details)) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
U.S Pension Plans
Changes in the pension and postretirement benefit obligations
Obligations at beginning of year	$ 2,190	$ 2,428
Change in benefit obligations:
Service cost	15	24	$ 22
Interest cost	90	96	105
Actuarial (gain) loss, including the effect of change in discount rates	36	(107)
Curtailment, settlement, and plan amendment	(200)
Benefit payments	(175)	(252)
Other		1
Net change in benefit obligations	(234)	(238)
Obligations at end of year	1,956	2,190	2,428
Non-U.S. Pension Plans
Changes in the pension and postretirement benefit obligations
Obligations at beginning of year	1,210	1,311
Change in benefit obligations:
Service cost	16	15	23
Interest cost	44	44	69
Actuarial (gain) loss, including the effect of change in discount rates	160	(9)
Acquisitions		37
Participant contributions	2	1
Benefit payments	(71)	(58)
Other	3
Foreign currency translation	(129)	(131)
Net change in benefit obligations	25	(101)
Obligations at end of year	1,235	1,210	1,311
U.S Postretirement Benefit Plans
Changes in the pension and postretirement benefit obligations
Obligations at beginning of year	97	111
Change in benefit obligations:
Interest cost	4	4	5
Actuarial (gain) loss, including the effect of change in discount rates	(1)	(10)
Benefit payments	(9)	(8)
Other	1
Net change in benefit obligations	(5)	(14)
Obligations at end of year	92	97	111
Non-U.S. Postretirement Benefit Plans
Changes in the pension and postretirement benefit obligations
Obligations at beginning of year	68	81
Change in benefit obligations:
Service cost	1	1	1
Interest cost	3	3	4
Actuarial (gain) loss, including the effect of change in discount rates	9	(1)
Benefit payments	(2)	(3)
Foreign currency translation	2	(13)
Net change in benefit obligations	13	(13)
Obligations at end of year	$ 81	$ 68	$ 81

Pensions Benefit Plans and Ot67

Pensions Benefit Plans and Other Postretirement Benefits - Changes in Fair Value of Pension Plan Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
U.S Pension Plans
Changes in fair value of pension plan assets
Fair value at beginning of year	$ 1,909	$ 2,190
Actual gain (loss) on plan assets	118	(32)
Benefit payments	(175)	(252)
Employer contributions	2	2
Settlements	(200)
Other		1
Net change in fair value of assets	(255)	(281)
Fair value at end of year	1,654	1,909
Non-U.S. Pension Plans
Changes in fair value of pension plan assets
Fair value at beginning of year	1,012	1,094
Actual gain (loss) on plan assets	139	42
Benefit payments	(71)	(58)
Employer contributions	38	15
Participant contributions	2	1
Acquisitions		22
Foreign currency translation	(111)	(104)
Other	2
Net change in fair value of assets	(1)	(82)
Fair value at end of year	$ 1,011	$ 1,012

Pensions Benefit Plans and Ot68

Pensions Benefit Plans and Other Postretirement Benefits - Funded Status (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Pension Benefit Plans
Defined Benefit Plan Disclosure
Percentage of minimum target plan asset allocations	10.00%
U.S Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	$ 1,654	$ 1,909	$ 2,190
Projected benefit and postretirement benefit obligations	1,956	2,190	2,428
Plan assets less than projected benefit obligations	(302)	(281)
Items not yet recognized in pension expense and net postretirement benefit cost:
Actuarial loss	1,046	1,145
Prior service cost (credit)	1	2
Total	1,047	1,147
Net amount recognized	745	866
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	1,011	1,012	1,094
Projected benefit and postretirement benefit obligations	1,235	1,210	1,311
Plan assets less than projected benefit obligations	(224)	(198)
Items not yet recognized in pension expense and net postretirement benefit cost:
Actuarial loss	352	320
Prior service cost (credit)	(1)	(1)
Total	351	319
Net amount recognized	127	121
U.S Postretirement Benefit Plans
Defined Benefit Plan Disclosure
Projected benefit and postretirement benefit obligations	92	97	111
Items not yet recognized in pension expense and net postretirement benefit cost:
Actuarial loss	(21)	(23)
Prior service cost (credit)	30	38
Total	9	15
Net amount recognized	(83)	(82)
Non-U.S. Postretirement Benefit Plans
Defined Benefit Plan Disclosure
Projected benefit and postretirement benefit obligations	81	68	$ 81
Items not yet recognized in pension expense and net postretirement benefit cost:
Actuarial loss	(6)	3
Total	(6)	3
Net amount recognized	$ (87)	$ (65)

Pensions Benefit Plans and Ot69

Pensions Benefit Plans and Other Postretirement Benefits - Net Amount Recognized Included in Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
U.S Pension Plans
Net amount recognized included in the Consolidated Balance Sheets
Current pension liability and nonpension postretirement benefit, included with Other accrued liabilities	$ (7)	$ (1)
Pension benefits and nonpension postretirement benefits	(295)	(280)
Accumulated other comprehensive loss	1,047	1,147
Net amount recognized	745	866
Non-U.S. Pension Plans
Net amount recognized included in the Consolidated Balance Sheets
Pension assets	40	32
Current pension liability and nonpension postretirement benefit, included with Other accrued liabilities	(7)	(6)
Pension benefits and nonpension postretirement benefits	(257)	(224)
Accumulated other comprehensive loss	351	319
Net amount recognized	127	121
U.S Postretirement Benefit Plans
Net amount recognized included in the Consolidated Balance Sheets
Current pension liability and nonpension postretirement benefit, included with Other accrued liabilities	(8)	(8)
Pension benefits and nonpension postretirement benefits	(84)	(89)
Accumulated other comprehensive loss	9	15
Net amount recognized	(83)	(82)
Non-U.S. Postretirement Benefit Plans
Net amount recognized included in the Consolidated Balance Sheets
Current pension liability and nonpension postretirement benefit, included with Other accrued liabilities	(3)	(2)
Pension benefits and nonpension postretirement benefits	(78)	(66)
Accumulated other comprehensive loss	(6)	3
Net amount recognized	$ (87)	$ (65)

Pension Benefit Plans and Oth70

Pension Benefit Plans and Other Postretirement Benefits - Changes in Plan Assets and Benefit Obligations Recognized in AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
U.S Pension Plans
Changes in plan assets and benefit obligations were recognized in accumulated other comprehensive income
Current year actuarial (gain) loss	$ 66	$ 95
Amortization of actuarial loss	(67)	(74)
Loss due to settlement	(98)
Total	(99)	21
Changes in benefit obligations were recognized in accumulated other comprehensive income	(99)	21
Non-U.S. Pension Plans
Changes in plan assets and benefit obligations were recognized in accumulated other comprehensive income
Current year actuarial (gain) loss	87	15
Amortization of actuarial loss	(12)	(15)
Total	75
Translation	(43)	(31)
Changes in benefit obligations were recognized in accumulated other comprehensive income	32	(31)
U.S Postretirement Benefit Plans
Changes in plan assets and benefit obligations were recognized in accumulated other comprehensive income
Current year actuarial (gain) loss	(1)	(10)
Amortization of actuarial loss	(1)	(2)
Amortization of prior service credit	8	8
Total	6	$ (4)
Non-U.S. Postretirement Benefit Plans
Changes in plan assets and benefit obligations were recognized in accumulated other comprehensive income
Current year actuarial (gain) loss	9
Total	$ 9

Pensions Benefit Plans and Ot71

Pensions Benefit Plans and Other Postretirement Benefits - Components of Net Periodic Pension and Postretirement Cost (Income) (Details) - USD ($) $ in Millions	Oct. 01, 2014	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Pension Benefit Plans
Amortization:
Accumulated benefit obligation		$ 3,126	$ 3,306
U.S Pension Plans
Components of net periodic pension cost
Service cost		15	24	$ 22
Interest cost		90	96	105
Expected asset return		(149)	(170)	(176)
Amortization:
Actuarial loss		67	74	68
Net amortization		67	74	68
Net periodic pension cost		23	24	19
Settlement cost		98		30
Non-U.S. Pension Plans
Components of net periodic pension cost
Service cost		16	15	23
Interest cost		44	44	69
Expected asset return		(65)	(67)	(86)
Amortization:
Actuarial loss		13	15	18
Net amortization		13	15	18
Net periodic pension cost		8	7	24
Settlement cost	$ 35			3
U.S Postretirement Benefit Plans
Components of net periodic pension cost
Interest cost		4	4	5
Amortization:
Actuarial loss		1	2	2
Prior service cost		(7)	(8)	(8)
Net amortization		(6)	(6)	(6)
Net periodic pension cost		(2)	(2)	(1)
Non-U.S. Postretirement Benefit Plans
Components of net periodic pension cost
Service cost		1	1	1
Interest cost		3	3	4
Amortization:
Net periodic pension cost		$ 4	$ 4	$ 5

Pensions Benefit Plans and Ot72

Pensions Benefit Plans and Other Postretirement Benefits - Amortized From AOCI (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)
U.S Pension Plans
Amortization:
Actuarial loss	$ 57
Prior service cost	1
Net amortization	58
Non-U.S. Pension Plans
Amortization:
Actuarial loss	16
Net amortization	16
U.S Postretirement Benefit Plans
Amortization:
Actuarial loss	(1)
Prior service cost	7
Net amortization	$ 6

Pensions Benefit Plans and Ot73

Pensions Benefit Plans and Other Postretirement Benefits - Projected and Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
U.S Pension Plans
Projected Benefit Obligation Exceeds the Fair Value of Plan Assets
Projected benefit obligations	$ 1,956	$ 2,190
Accumulated benefit obligation	1,956	2,160
Fair value of plan assets	1,654	1,909
Accumulated Benefit Obligations Exceeds the Fair Value of Plan Assets
Projected benefit obligations	1,956	2,190
Accumulated benefit obligation	1,956	2,160
Fair value of plan assets	1,654	1,909
Non-U.S. Pension Plans
Projected Benefit Obligation Exceeds the Fair Value of Plan Assets
Projected benefit obligations	897	876
Accumulated benefit obligation	867	850
Fair value of plan assets	632	645
Accumulated Benefit Obligations Exceeds the Fair Value of Plan Assets
Projected benefit obligations	897	876
Accumulated benefit obligation	867	850
Fair value of plan assets	$ 632	$ 645

Pensions Benefit Plans and Ot74

Pensions Benefit Plans and Other Postretirement Benefits - Weighted Average Assumptions (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Weighted average assumptions used to determine net periodic pension costs and net postretirement benefit cost
Tenure used for computing historical long-term rate of return assumption	10 years
U.S Pension Plans
Weighted average assumptions used to determine pension and accumulated postretirement benefit obligations
Discount rate used to determine pension and accumulated postretirement benefit obligations (as a percent)	4.17%	4.43%
Rate of compensation increase (as a percent)		2.97%
Weighted average assumptions used to determine net periodic pension costs and net postretirement benefit cost
Discount rate used to determine net periodic pension costs and net postretirement benefit cost (as a percent)	4.43%	4.05%	4.81%
Rate of compensation increase (as a percent)	2.97%	2.96%	2.97%
Expected long-term rate of return on assets (as a percent)	7.50%	8.00%	8.00%
Non-U.S. Pension Plans
Weighted average assumptions used to determine pension and accumulated postretirement benefit obligations
Discount rate used to determine pension and accumulated postretirement benefit obligations (as a percent)	2.94%	3.68%
Rate of compensation increase (as a percent)	2.90%	2.84%
Weighted average assumptions used to determine net periodic pension costs and net postretirement benefit cost
Discount rate used to determine net periodic pension costs and net postretirement benefit cost (as a percent)	3.68%	3.65%	4.14%
Rate of compensation increase (as a percent)	2.84%	2.89%	3.31%
Expected long-term rate of return on assets (as a percent)	7.15%	7.21%	7.23%
U.S Postretirement Benefit Plans
Weighted average assumptions used to determine pension and accumulated postretirement benefit obligations
Discount rate used to determine pension and accumulated postretirement benefit obligations (as a percent)	4.11%	4.35%	4.00%
Weighted average assumptions used to determine net periodic pension costs and net postretirement benefit cost
Discount rate used to determine net periodic pension costs and net postretirement benefit cost (as a percent)	4.34%	3.99%	4.63%
Non-U.S. Postretirement Benefit Plans
Weighted average assumptions used to determine pension and accumulated postretirement benefit obligations
Discount rate used to determine pension and accumulated postretirement benefit obligations (as a percent)	3.55%	3.80%	3.75%
Weighted average assumptions used to determine net periodic pension costs and net postretirement benefit cost
Discount rate used to determine net periodic pension costs and net postretirement benefit cost (as a percent)	3.80%	3.75%	4.47%

Pensions Benefit Plans and Ot75

Pensions Benefit Plans and Other Postretirement Benefits - U.S. Plan Assets By Hierarchy (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan Disclosure
Investments measured at net asset value	$ 901	$ 931
U.S Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	1,654	1,909	$ 2,190
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	1,011	1,012	1,094
Total non-U.S. assets at fair value		1,012
Cash and cash equivalents | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	$ 24	30
Equity securities | U.S Pension Plans
Defined Benefit Plan Disclosure
Percentage of pension plan assets	62.00%
Equity securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Percentage of pension plan assets	41.00%
Debt securities | U.S Pension Plans
Defined Benefit Plan Disclosure
Percentage of pension plan assets	31.00%
Debt securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Percentage of pension plan assets	42.00%
Plan assets at fair value	$ 39	16
Real estate | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	4	5
Other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	$ 43	30
Real estate and other | U.S Pension Plans
Defined Benefit Plan Disclosure
Percentage of pension plan assets	7.00%
Real estate and other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Percentage of pension plan assets	17.00%
Level 1 | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	$ 61	46
Level 1 | Cash and cash equivalents | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	24	30
Level 1 | Debt securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	37	16
Level 2 | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	39	24
Level 2 | Debt securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	2
Level 2 | Other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	37	24
Level 3 | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	10	11	$ 5
Level 3 | Real estate | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	4	5
Level 3 | Other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Plan assets at fair value	$ 6	$ 6

Pensions Benefit Plans and Ot76

Pensions Benefit Plans and Other Postretirement Benefits - Reconciliation of Pension Plan Assets Using Significant Unobservable Inputs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
U.S Pension Plans
Defined Benefit Plan Disclosure
Fair value at beginning of year	$ 1,909	$ 2,190
Net increase (decrease)	(255)	(281)
Fair value at end of year	1,654	1,909
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Fair value at beginning of year	1,012	1,094
Net increase (decrease)	(1)	(82)
Fair value at end of year	1,011	1,012
Other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Fair value at beginning of year	30
Fair value at end of year	43	30
Level 3 | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Fair value at beginning of year	11	5
Net increase (decrease)	(1)	6
Fair value at end of year	10	11
Level 3 | Other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Fair value at beginning of year	6
Fair value at end of year	$ 6	$ 6

Pensions Benefit Plans and Ot77

Pensions Benefit Plans and Other Postretirement Benefits - Minimum Funding Requirements and Estimated Future Benefit Payments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan Disclosure
Defined contribution plans for salaried and hourly U.S. employees	$ 34	$ 29	$ 19
U.S Pension Plans
Estimated future benefit payments
2,017	157
2,018	146
2,019	145
2,020	143
2,021	140
2022 - 2026	656
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure
Contribution to defined benefit plan in 2017	32
Estimated future benefit payments
2,017	53
2,018	51
2,019	54
2,020	57
2,021	60
2022 - 2026	343
U.S Postretirement Benefit Plans
Estimated future benefit payments
2,017	8
2,018	8
2,019	8
2,020	8
2,021	7
2022 - 2026	30
Non-U.S. Postretirement Benefit Plans
Estimated future benefit payments
2,017	3
2,018	3
2,019	3
2,020	3
2,021	3
2022 - 2026	$ 18

Pensions Benefit Plans and Ot78

Pensions Benefit Plans and Other Postretirement Benefits Weighted Average Assumptions Assumed and Effect of Percentage Point Change in Health Care Cost Trend (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan Disclosure
Payments to the trust as required by the bargaining agreements are based upon specified amounts per hour worked	$ 6	$ 6	$ 6
U.S Postretirement Benefit Plans
Weighted average assumed health care cost trend (in percent)
Health care cost trend rate assumed for next year (as a percent)	6.40%	6.60%
Rate to which the cost trend rate is assumed to decline (ultimate trend rate) (as a percent)	5.00%	5.00%
Year that the rate reaches the ultimate trend rate	2,024	2,024
Effect of one-percentage-point change in assumed health care cost trend rates (in percent)
One-Percentage-Point Increase, effect on accumulated postretirement benefit obligations	$ 4
One-Percentage-Point Decrease, effect on accumulated postretirement benefit obligations	$ (3)
Non-U.S. Postretirement Benefit Plans
Weighted average assumed health care cost trend (in percent)
Health care cost trend rate assumed for next year (as a percent)	5.00%	5.00%
Rate to which the cost trend rate is assumed to decline (ultimate trend rate) (as a percent)	5.00%	5.00%
Effect of one-percentage-point change in assumed health care cost trend rates (in percent)
One-Percentage-Point Increase, effect on total of service and interest cost	$ 1
One-Percentage-Point Decrease, effect on total of service and interest cost	(1)
One-Percentage-Point Increase, effect on accumulated postretirement benefit obligations	13
One-Percentage-Point Decrease, effect on accumulated postretirement benefit obligations	$ (10)

Income Taxes - Income (Loss) Be

Income Taxes - Income (Loss) Before Taxes and Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Continuing operations
U.S.	$ (27)		$ 36
Non-U.S.	383	$ 268	271
Earnings from continuing operations before income taxes	356	268	307
Discontinued operations;
U.S.			(19)
Non-U.S.	(7)	(4)	(4)
Discontinued operations total	(7)	(4)	(23)
Current:
U.S.		9	7
Non-U.S.	123	85	103
Total	123	94	110
Deferred:
U.S.	3	10
Non-U.S.	(7)	2	(18)
Total	(4)	12	(18)
Total:
U.S.	3	19	7
Non-U.S.	116	87	85
Total for continuing operations	119	106	92
Total	$ 119	$ 106	$ 92

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of the Provision (Benefit) for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
A reconciliation of the provision (benefit) for income taxes
Statutory U.S. Federal tax rate (as a percent)	35.00%
Increase (decrease) in provision for income taxes due to:
Tax provision on pretax earnings (loss) from continuing operations at statutory U.S. Federal tax rate	$ 124	$ 94	$ 107
Non-U.S. tax rates	(22)	(12)	(22)
Changes in valuation allowance	3	1	(2)
Withholding tax, net	22	18	18
Non-deductible acquisition costs		6
U.S. tax on intercompany dividends and interest	3	16	1
Tax exempt income	(2)	(3)	(5)
Intraperiod tax allocation	(8)
Tax law changes	(3)	(3)
Tax credit	(19)	(14)	(3)
Change in tax reserves	8	5	(13)
Mexico inflationary adjustment	6	3
Other items	7	(5)	11
Provision for income taxes	$ 119	$ 106	$ 92

Income Taxes - Deferred Taxes (

Income Taxes - Deferred Taxes (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Deferred tax assets:
Accrued postretirement benefits	$ 53	$ 51
Asbestos-related liabilities	242	286
Foreign tax credit	413	389
Operating and capital loss carryovers	389	435
Other credit carryovers	34	38
Accrued liabilities	95	82
Pension liability	138	128
Other	74	63
Total deferred tax assets	1,438	1,472
Deferred tax liabilities:
Property, plant, and equipment	131	128
Intangibles and deferred software	119	131
Other	9	25
Total deferred tax liabilities	259	284
Valuation allowance	(1,094)	(1,135)
Net deferred taxes	85	53
Deferred taxes are included in the Consolidated Balance Sheets:
Other assets	185	177
Deferred taxes	(100)	(124)
Net deferred taxes	$ 85	$ 53

Income Taxes - Possible Changes

Income Taxes - Possible Changes and Reconciliation of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reasonably possible change in unrecognized tax benefits
Unused foreign tax credits expiring in 2017 through 2026	$ 413	$ 389
Unused research tax credits expiring from 2019 to 2036	14
Alternative minimum tax credits	18
Operating and capital loss carryforwards with indefinite life	151
Operating and capital loss carryforwards expiring between 2017 and 2036	238
Valuation allowance	1,094	1,135
Equity in undistributed earnings of foreign subsidiaries	2,200
Reconciliation of the Company's total gross unrecognized tax benefits
Balance at beginning of the period	74	77	$ 100
Additions and reductions for tax positions of prior years		1
Additions and reductions for tax positions of prior years			(13)
Additions based on tax positions related to the current year	15	10	10
Reduction due to lapse of the applicable statute of limitations	(3)	(5)	(8)
Reductions due to settlements	(12)	(1)	(1)
Foreign currency translation		(8)	(11)
Balance at ending of the period	74	74	77
Unrecognized tax benefits, which if recognized, would impact the Company's effective income tax rate	66	67	70
Accrued interest and penalties	23	25	29
Interest and penalties included in tax expense	$ (2)	$ (1)	$ (2)
Period during which unrecognized tax benefits are reasonably possible of being settled as a result of audit settlements or statute expirations	12 months
Maximum
Reconciliation of the Company's total gross unrecognized tax benefits
Reasonably possible decrease in unrecognized tax benefits related to audit settlements or statute expirations	$ 11

Debt (Details)

Debt (Details) $ / shares in Units, € in Millions, $ in Millions	Apr. 22, 2015item	Nov. 30, 2016USD ($)	Aug. 31, 2015USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2016EUR (€)	Dec. 31, 2016USD ($)$ / shares	Nov. 30, 2016EUR (€)	Feb. 03, 2016	Sep. 01, 2015USD ($)
Debt Instrument
Total long-term debt					$ 5,413			$ 5,166
Less amounts due within one year					68			33
Long-term debt					5,345			5,133
Net proceeds, after deducting debt issuance costs				$ 1,235	4,538	$ 1,247
Accounts receivable securitization
Short-term loans and long-term debt due within one year					228			195
The Agreement, Senior Secured Credit Facility
Debt Instrument
Leverage ratio, period one										4.50%
Leverage ratio, period two										4.00%
Number financial maintenance covenants | item	1
Senior Secured Credit Agreement
Debt Instrument
Unused Credit								$ 884
Accounts receivable securitization
Weighted average interest rate, short-term debt (as a percent)							2.39%	2.39%
Term Loan A
Debt Instrument
Total long-term debt					1,546			$ 1,395
Face Value								1,575
Net proceeds, after deducting debt issuance costs				1,395
Term Loan A (279 million EUR at December 31, 2016)
Debt Instrument
Total long-term debt					301		€ 279	282
Face Value | €							279
Net proceeds, after deducting debt issuance costs				$ 282
Term Loan B (USD tranche)
Debt Instrument
Total long-term debt					563
Senior Notes 6.75%, due 2020 (500 million EUR)
Debt Instrument
Total long-term debt					542		€ 500	$ 523
Interest rate, stated percentage							6.75%	6.75%
Fair values of fixed rate debt obligations
Principal Amount								$ 526
Indicated Market Price (in dollars per share) | $ / shares								$ 120.63
Fair Value								$ 635
Senior Notes 4.875%, due 2021 (330 million EUR)
Debt Instrument
Total long-term debt					357		€ 330	$ 345
Interest rate, stated percentage							4.875%	4.875%
Fair values of fixed rate debt obligations
Principal Amount								$ 347
Indicated Market Price (in dollars per share) | $ / shares								$ 114
Fair Value								$ 396
Senior Notes 5.00%, due 2022
Debt Instrument
Total long-term debt					494			$ 495
Interest rate, stated percentage							5.00%	5.00%
Fair values of fixed rate debt obligations
Principal Amount								$ 500
Indicated Market Price (in dollars per share) | $ / shares								$ 103.49
Fair Value								$ 517
Senior Notes 5.875% due 2023
Debt Instrument
Total long-term debt					680			$ 682
Interest rate, stated percentage							5.875%	5.875%
Fair values of fixed rate debt obligations
Principal Amount								$ 700
Indicated Market Price (in dollars per share) | $ / shares								$ 105.37
Fair Value								$ 738
Senior Notes 3.125%, due 2024 (500 million EUR)
Debt Instrument
Total long-term debt							€ 500	$ 520
Interest rate, stated percentage							3.125%	3.125%	3.125%
Face Value | €									€ 500
Net proceeds, after deducting debt issuance costs		$ 520
Fair values of fixed rate debt obligations
Principal Amount								$ 526
Indicated Market Price (in dollars per share) | $ / shares								$ 100.01
Fair Value								$ 526
Senior Notes 5.375%, due 2025
Debt Instrument
Total long-term debt					296			$ 297
Interest rate, stated percentage							5.375%	5.375%
Fair values of fixed rate debt obligations
Principal Amount								$ 300
Indicated Market Price (in dollars per share) | $ / shares								$ 106.28
Fair Value								$ 319
Senior Notes 6.375%, due 2025
Debt Instrument
Total long-term debt					293			$ 294
Interest rate, stated percentage							6.375%	6.375%
Fair values of fixed rate debt obligations
Principal Amount								$ 300
Indicated Market Price (in dollars per share) | $ / shares								$ 101.17
Fair Value								$ 304
Senior Debentures 7.80%, due 2018
Debt Instrument
Total long-term debt					250			$ 250
Interest rate, stated percentage							7.80%	7.80%
Fair values of fixed rate debt obligations
Principal Amount								$ 250
Indicated Market Price (in dollars per share) | $ / shares								$ 106.26
Fair Value								$ 266
Capital leases
Debt Instrument
Total long-term debt					62			57
Other
Debt Instrument
Total long-term debt					29			26
Revolving Credit Facility | The Agreement, Senior Secured Credit Facility
Debt Instrument
Total long-term debt								300
Multicurrency Revolving Credit Facility | The Agreement, Senior Secured Credit Facility
Debt Instrument
Total long-term debt								600
Accounts Receivable Securitization Program
Accounts receivable securitization
Short-term loans and long-term debt due within one year					$ 158			$ 152
Weighted average interest rate, short-term debt (as a percent)					1.21%		0.74%	0.74%
European Accounts Receivable Securitization Program
Accounts receivable securitization
Maximum Borrowing Capacity | €							€ 185
Minimum | Term Loan A | The Agreement, Senior Secured Credit Facility
Debt Instrument
Interest rate margin, Eurocurrency Rate loans (as a percent)	1.25%
Interest rate margin, Base Rate loans (as a percent)	0.25%
Minimum | Revolving Credit Facility
Debt Instrument
Facility fee payable (as a percent)	0.20%
Maximum | Term Loan A | The Agreement, Senior Secured Credit Facility
Debt Instrument
Interest rate margin, Eurocurrency Rate loans (as a percent)	1.75%
Interest rate margin, Base Rate loans (as a percent)	0.75%
Maximum | Revolving Credit Facility
Debt Instrument
Facility fee payable (as a percent)	0.30%
Vitro Acquisition | The Agreement, Senior Secured Credit Facility
Debt Instrument
Face Value											$ 1,250
Net proceeds, after deducting debt issuance costs			$ 972
Vitro Acquisition | Term Loan A
Debt Instrument
Face Value											675
Vitro Acquisition | Term Loan B (USD tranche)
Debt Instrument
Face Value											$ 575
Vitro Acquisition | Senior Notes 5.875% due 2023
Debt Instrument
Interest rate, stated percentage			5.875%
Face Value			$ 700
Vitro Acquisition | Senior Notes 6.375%, due 2025
Debt Instrument
Interest rate, stated percentage			6.375%
Face Value			$ 300

Debt - Annual Maturities of Lon

Debt - Annual Maturities of Long-Term Debt (Details) $ in Millions	Dec. 31, 2016USD ($)
Annual maturities of long-term debt through 2018
2,017	$ 33
2,018	287
2,019	101
2,020	2,074
2,021	$ 354

Contingencies - Asbestos (Detai

Contingencies - Asbestos (Details)	12 Months Ended
	Dec. 31, 2016USD ($)itemplaintiff	Dec. 31, 2015USD ($)item	Dec. 31, 2014USD ($)item	Dec. 31, 2013item	Dec. 31, 1993USD ($)
Asbestos
Sale of goods containing asbestos from 1948 to 1958	$ 40,000,000
Number of pending plaintiffs and claimants | item	1,400	2,080	2,260	2,620
Approximate number of claims disposed of to date | plaintiff	398,000
Average indemnity payment per claim	$ 9,000
Payments for Asbestos-Related Liabilities	125,000,000	$ 138,000,000	$ 148,000,000
Cash payments per claim disposed including legal costs	71,000	95,000	81,000
Asbestos-related liability, total amount accrued beginning in 1993 through 2016 before insurance recoveries	$ 4,900,000,000				$ 975,000,000
Number of years, estimate of accrued liability	10 years
Accrual of asbestos related liability	$ 692,000,000	817,000,000
Asbestos related charges	$ 0	$ 16,000,000	$ 46,000,000
Approximate number of plaintiffs and claimants asbestos claims pending against the entity
Disposed (in number of litigants) | item	1,750	1,460	1,830
Filed (in number of litigants) | item	1,070	1,280	1,470
Maximum
Asbestos
Loss contingency, plaintiffs damages	$ 825,000,000
Damages unspecified or sufficient to invoke jurisdictional minimum
Asbestos
Percentage of asbestos plaintiffs, approximate percentage	88.00%
Damages of $15 million or less
Asbestos
Percentage of asbestos plaintiffs, approximate percentage	9.00%
Damages of $15 million or less | Minimum
Asbestos
Loss contingency, plaintiffs damages	$ 15,000,000
Damages greater than $15 million but less than $100 million
Asbestos
Percentage of asbestos plaintiffs, approximate percentage	3.00%
Damages greater than $15 million but less than $100 million | Minimum
Asbestos
Loss contingency, plaintiffs damages	$ 15,000,000
Damages greater than $15 million but less than $100 million | Maximum
Asbestos
Loss contingency, plaintiffs damages	$ 100,000,000

Accumulated Other Comprehensi86

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	$ (2,017)
Balance	279	$ 771	$ 1,010
Intraperiod tax allocation	(8)
Other comprehensive loss	(159)	(539)	(394)
Balance at end of the period	(2,172)	(2,017)
Balance	363	279	771
Net Effect of Exchange Rate Fluctuations
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(568)	(55)
Change before reclassifications	(220)	(513)
Other comprehensive loss	(220)	(513)
Balance at end of the period	(788)	(568)	(55)
Change in Certain Derivative Instruments
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(17)	(11)
Change before reclassifications	7	(4)
Amounts reclassified from accumulated other comprehensive income	6	(1)
Tax effect		(1)
Other comprehensive loss	13	(6)
Balance at end of the period	(4)	(17)	(11)
Employee Benefit Plans
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(1,432)	(1,428)
Change before reclassifications	(2)	(58)
Amounts reclassified from accumulated other comprehensive income	72	83
Translation effect	(25)	(31)
Tax effect	15	2
Intraperiod tax allocation	(8)
Other comprehensive loss	52	(4)
Balance at end of the period	(1,380)	(1,432)	(1,428)
Accumulated Other Comprehensive Loss
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(2,017)	(1,494)
Balance	(2,017)	(1,494)	(1,121)
Change before reclassifications	(215)	(575)
Amounts reclassified from accumulated other comprehensive income	78	82
Translation effect	(25)	(31)
Tax effect	15	1
Intraperiod tax allocation	(8)
Other comprehensive loss	(155)	(523)
Balance at end of the period	(2,172)	(2,017)	(1,494)
Balance	$ (2,172)	$ (2,017)	$ (1,494)

Stock Options and Other Stock87

Stock Options and Other Stock Based Compensation - Share-based Compensation Arrangement by Share-based Payment Award (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award
Shares available for grants under the plans	5,081,000
Compensation cost for all grants of shares and units	$ 15	$ 15	$ 21
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Number of options may be exercised in whole or in part during the first year after the date granted	504,000
Stock Options | Shares granted to employees after March 21, 2005
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of options exercisable per year beginning on the first anniversary from date of option granted	25.00%
Stock Options | Shares granted to employees after March 21, 2005 | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Fair value of options, amortization period	1 year
Stock Options | Shares granted to employees after March 21, 2005 | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Fair value of options, amortization period	4 years

Stock Options and Other Stock88

Stock Options and Other Stock Based Compensation - Options (Details) - Stock Options - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Number of Shares
Options outstanding, Beginning balance (in shares)	2,621
Granted (in shares)	1,098
Exercised (in shares)	(504)
Forfeited or expired (in shares)	(119)
Options outstanding, ending balance (in shares)	3,096	2,621
Options vested or expected to vest (in shares)	3,096
Options exercisable (in shares)	1,342
Weighted Average Exercise Price (per share)
Options outstanding, Beginning balance (in dollars per share)	$ 23.64
Granted (in dollars per share)	15.10
Exercised (in dollars per share)	10.13
Forfeited or expired (in dollars per share)	21.24
Options outstanding, Closing balance (in dollars per share)	22.91	$ 23.64
Options vested or expected to vest (in dollars per share)	22.91
Options exercisable (in dollars per share)	$ 27.71
Weighted Average Remaining Contractual Term (in years)
Options outstanding, Closing balance	4 years 2 months 12 days
Options vested or expected to vest	2 years 3 months 18 days
Options exercisable	4 years 2 months 12 days
Aggregate Intrinsic Value
Options outstanding, Closing balance (in dollars)	$ 3
Options vested or expected to vest (in dollars)	$ 3
Weighted average grant-date fair value of options granted (in dollars per share)	$ 4.98	$ 7.79	$ 13.17
Aggregate intrinsic value of options exercised (in dollars)	$ 2		$ 3
Aggregate cash received from options exercised (in dollars)	$ 5	$ 1	$ 5
Weighted average assumptions used to estimate the fair value of each option grant
Expected life of options (years)	5 years 2 months 12 days	5 years	5 years
Expected stock price volatility (as a percent)	32.80%	34.50%	43.00%
Risk-free interest rate (as a percent)	1.50%	1.70%	1.60%
Expected dividend yield (as a percent)	0.00%	0.00%	0.00%

Stock Options and Other Stock89

Stock Options and Other Stock Based Compensation - Restricted share and Restricted Share Units and Performance Vested Restricted Share Units (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)$ / sharesshares	Dec. 31, 2014USD ($)$ / shares
Restricted share and Restricted Share Units and Performance Vested Restricted Share Units
Unrecognized compensation cost of unvested stock options, restricted shares, restricted share units and performance vested restricted share units (in dollars) | $	$ 17
Weighted average period during which unrecognized compensation costs would be recognized	2 years
Restricted Shares and Restricted Share Units
Restricted share and Restricted Share Units and Performance Vested Restricted Share Units
Nonvested, beginning balance (in shares)	672,000
Granted (in shares)	389,000
Vested (in shares)	(215,000)
Forfeited (in shares)	(10,000)
Nonvested, ending balance (in shares)	836,000	672,000
Nonvested, Beginning balance (in dollars per share) | $ / shares	$ 23.66
Granted (in dollars per share) | $ / shares	15.70	$ 22.69	$ 33.36
Vested (in dollars per share) | $ / shares	25.88
Forfeited (in dollars per share) | $ / shares	21.11
Nonvested, Closing balance (in dollars per share) | $ / shares	$ 19.42	$ 23.66
Total fair value of shares issued (in dollars) | $	$ 6	$ 4	$ 5
Restricted Shares and Restricted Share Units | Shares granted to employees after March 21, 2005
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of shares vested per year beginning on first anniversary	25.00%
Restricted Shares and Restricted Share Units | Shares granted to employees after March 21, 2005 | Minimum
Restricted share and Restricted Share Units and Performance Vested Restricted Share Units
Fair value of restricted shares, amortization period	1 year
Restricted Shares and Restricted Share Units | Shares granted to employees after March 21, 2005 | Maximum
Restricted share and Restricted Share Units and Performance Vested Restricted Share Units
Fair value of restricted shares, amortization period	4 years
Restricted Share Units | Shares granted to directors after 2007
Share-based Compensation Arrangement by Share-based Payment Award
Period after which shares granted can be vested	1 year
Restricted Share Units | Shares granted to employees after 2010
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of shares vested per year beginning on first anniversary	25.00%
Common stock distribution ratio	1
Performance Vested Restricted Share Units
Share-based Compensation Arrangement by Share-based Payment Award
Period after which shares granted can be vested	3 years
Restricted share and Restricted Share Units and Performance Vested Restricted Share Units
Nonvested, beginning balance (in shares)	933,000
Granted (in shares)	726,000
Vested (in shares)	(158,000)
Forfeited (in shares)	(146,000)
Nonvested, ending balance (in shares)	1,355,000	933,000
Nonvested, Beginning balance (in dollars per share) | $ / shares	$ 26.80
Granted (in dollars per share) | $ / shares	15.10	$ 23.63	$ 33.41
Vested (in dollars per share) | $ / shares	26.10
Forfeited (in dollars per share) | $ / shares	25.41
Nonvested, Closing balance (in dollars per share) | $ / shares	$ 20.76	$ 26.80
Total fair value of shares vested (in dollars) | $	$ 4
Shares issued	158,000
Performance Vested Restricted Share Units | Maximum
Restricted share and Restricted Share Units and Performance Vested Restricted Share Units
Shares of common stock holder may receive, per unit of vested units	2

Other Expense, net (Details)

Other Expense, net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Other Expense, net
Restructuring, asset impairment and other charges	$ 104	$ 75	$ 68
Intangible amortization expense	39	21	1
Impairment of equity investment	25
Charge for asbestos related costs	0	16	46
Gain on China land compensation	(71)
Royalty income	(13)	(12)	(12)
Strategic transaction costs		23
Acquisition-related fair value intangible adjustments		10
Non-income tax charge			69
Foreign currency exchange gain (loss)	6	(10)	(2)
Other expense (income)	(14)	(12)	24
Other Expense (Income), net	$ 76	$ 111	$ 194

Operating Leases (Details)

Operating Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating Leases
Rent expense attributable to warehouse, office buildings and equipment operating leases	$ 80	$ 72	$ 63
Minimum future rentals under operating leases
2,017	65
2,018	47
2,019	32
2,020	23
2,021	14
2022 and thereafter	$ 24

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Numerator:
Net earnings attributable to the Company	$ 209	$ 135	$ 164
Denominator (in thousands):
Denominator for basic earnings per share - weighted average shares outstanding (in shares)	161,857,000	161,169,000	164,720,000
Effect of dilutive securities:
Stock options and other (in shares)	968,000	966,000	1,327,000
Denominator for diluted earnings per share - adjusted weighted average shares outstanding (in shares)	162,825,000	162,135,000	166,047,000
Basic earnings per share:
Earnings from continuing operations (in dollars per share)	$ 1.33	$ 0.86	$ 1.14
Loss from discontinued operations (in dollars per share)	(0.04)	(0.03)	(0.14)
Net earnings (in dollars per share)	1.29	0.83	1
Diluted earnings per share:
Earnings from continuing operations (in dollars per share)	1.32	0.85	1.13
Loss from discontinued operations (in dollars per share)	(0.04)	(0.03)	(0.14)
Net earnings (in dollars per share)	$ 1.28	$ 0.82	$ 0.99
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares)	2,770,458	1,937,315	1,143,933

Supplemental Cash Flow Inform93

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Supplemental Cash Flow Information
Interest paid note repurchase premiums	$ 9	$ 32	$ 9
Decrease (increase) in current assets:
Receivables	(32)	(14)	59
Inventories	16	(13)	(26)
Prepaid expenses and other	145	(4)	(1)
Increase (decrease) in current liabilities:
Accounts payable	(58)	100	103
Accrued liabilities	(31)	21	12
Salaries and wages	32	12	(3)
U.S. and foreign income taxes	18	(14)	(27)
Changes in components of working capital, total	90	88	117
Amount of receivables sold	318	317
Interest paid in cash	261	227	199
Income taxes paid in cash (all non-US)	$ 99	$ 101	$ 101

Business Combinations (Details)

Business Combinations (Details) $ in Millions	Sep. 01, 2015USD ($)facility	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2013USD ($)
Business Combinations
Net sales		$ 6,702	$ 6,156	$ 6,784
Gross profit		1,212	1,110	1,253
Fair values of the assets and liabilities assumed
Goodwill		2,462	$ 2,489	$ 1,893	$ 2,462	$ 2,059
Vitro Acquisition
Business Combinations
Total consideration	$ 2,297
Number of plants acquired | facility	5
Net sales					608
Gross profit					122
Fair values of the assets and liabilities assumed
Cash	$ 17	17			17
Other current assets	344	334			334
Goodwill	1,073	837			837
Customer list intangibles	406	608			608
Net property, plant, and equipment	597	645			645
Total assets	2,437	2,441			2,441
Current liabilities	93	86			86
Long-term debt	11	11			11
Long-term liabilities	36	47			47
Net assets acquired	$ 2,297	2,297			2,297
Vitro Acquisition | As Adjusted
Fair values of the assets and liabilities assumed
Other current assets		(10)			(10)
Goodwill		(236)			(236)
Customer list intangibles		202			202
Net property, plant, and equipment		48			48
Total assets		4			4
Current liabilities		(7)			(7)
Long-term liabilities		$ 11			$ 11

Pro Forma Information - Vitro95

Pro Forma Information - Vitro Acquisition (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)$ / shares
Business Combinations, Pro Forma
Net sales	$ 6,730
Earnings (loss) from continuing operations attributable to the Company	$ 172
Diluted earnings per share from continuing operations | $ / shares	$ 1.06
As Reported
Business Combinations, Pro Forma
Net sales	$ 6,156
Earnings (loss) from continuing operations attributable to the Company	$ 139
Diluted earnings per share from continuing operations | $ / shares	$ 0.85
Acquisition Adjustments
Business Combinations, Pro Forma
Net sales	$ 574
Earnings (loss) from continuing operations attributable to the Company	79
Financing Adjustments
Business Combinations, Pro Forma
Earnings (loss) from continuing operations attributable to the Company	$ (46)

Discontinued Operations (Detail

Discontinued Operations (Details) $ in Millions	Apr. 04, 2016facility	Dec. 31, 2016USD ($)item	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Subsidiaries
Litigation Settlement, Amount		$ 485
Number of ICSID member states in which award is enforceable | item		150
Loss from discontinued operations		$ 7	$ 4	$ 23
Disposed Venezuelan subsidiaries
Subsidiaries
Expropriated plants | facility	2
Disposed Venezuelan subsidiaries | Discontinued Operations, Disposed of by Means Other than Sale
Subsidiaries
Loss from discontinued operations		$ 7	$ 4	$ 23

Financial Information for Sub97

Financial Information for Subsidiary Guarantors and Non-Guarantors - Balance Sheet (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)item	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Financial Information for Subsidiary Guarantors and Non Guarantors
Number of subsidiaries that have guaranteed the notes | item	2
Ownership percentage in Guarantor Subsidiaries	100.00%
Current assets:
Cash and cash equivalents	$ 492	$ 399
Trade receivables, net	580	562
Inventories	983	1,007
Prepaid expenses and other current assets	199	366
Total current assets	2,254	2,334
Property, plant and equipment, net	2,880	2,961	$ 2,445
Goodwill	2,462	2,489	1,893	$ 2,059
Intangibles	464	597
Total assets	9,135	9,421	$ 7,843
Other non-current assets	1,075	1,040
Current liabilities:
Short-term loans and long-term debt due within one year	195	228
Current portion of asbestos liability	115	130
Accounts payable	1,135	1,212
Other liabilities	615	552
Total current liabilities	2,060	2,122
Long-term debt	5,133	5,345
Asbestos-related liabilities	577	687
Other long-term liabilities	1,002	988
Share owners’ equity	254	171
Noncontrolling interests	109	108
Total liabilities and share owners' equity	9,135	9,421
Eliminations
Current assets:
Investments in and advances to subsidiaries	(2,144)	(2,228)
Total assets	(2,144)	(2,228)
Current liabilities:
Other liabilities	(2)	(2)
Total current liabilities	(2)	(2)
Long-term debt	(250)	(250)
Share owners’ equity	(1,892)	(1,976)
Total liabilities and share owners' equity	(2,144)	(2,228)
Parent
Current assets:
Investments in and advances to subsidiaries	1,198	1,240
Total assets	1,198	1,240
Current liabilities:
Current portion of asbestos liability	115	130
Other liabilities	2	2
Total current liabilities	117	132
Long-term debt	250	250
Asbestos-related liabilities	577	687
Share owners’ equity	254	171
Total liabilities and share owners' equity	1,198	1,240
Guarantor Subsidiaries
Current assets:
Investments in and advances to subsidiaries	946	988
Total assets	946	988
Current liabilities:
Share owners’ equity	946	988
Total liabilities and share owners' equity	946	988
Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	492	399
Trade receivables, net	580	562
Inventories	983	1,007
Prepaid expenses and other current assets	199	366
Total current assets	2,254	2,334
Property, plant and equipment, net	2,880	2,961
Goodwill	2,462	2,489
Intangibles	464	597
Total assets	9,135	9,421
Other non-current assets	1,075	1,040
Current liabilities:
Short-term loans and long-term debt due within one year	195	228
Accounts payable	1,135	1,212
Other liabilities	615	552
Total current liabilities	1,945	1,992
Long-term debt	5,133	5,345
Other long-term liabilities	1,002	988
Share owners’ equity	946	988
Noncontrolling interests	109	108
Total liabilities and share owners' equity	$ 9,135	$ 9,421

Financial Information for Sub98

Financial Information for Subsidiary Guarantors and Non-Guarantors - Results of Operations and Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Results of Operations
Net sales	$ 6,702	$ 6,156	$ 6,784
Cost of goods sold	(5,490)	(5,046)	(5,531)
Gross profit	1,212	1,110	1,253
Selling and administrative expense	(503)	(476)	(523)
Research, development and engineering expense	(65)	(64)	(63)
Interest expense, net	(272)	(251)	(230)
Other equity earnings	60	60	64
Other expense, net	(76)	(111)	(194)
Earnings from continuing operations before income taxes	356	268	307
Provision for income taxes	(119)	(106)	(92)
Earnings from continuing operations	237	162	215
Loss from discontinued operations	(7)	(4)	(23)
Net earnings	230	158	192
Net (earnings) attributable to noncontrolling interests	(21)	(23)	(28)
Net earnings	209	135	164
Comprehensive Income
Net earnings	230	158	192
Other comprehensive income (loss), net	(159)	(539)	(394)
Total comprehensive income (loss)	71	(381)	(202)
Comprehensive income attributable to noncontrolling interests	(17)	(7)	(7)
Comprehensive income (loss) attributable to the Company	54	(388)	(209)
Parent
Results of Operations
Net intercompany interest	20	20	20
Interest expense, net	(20)	(20)	(20)
Equity earnings from subsidiaries	209	151	210
Other expense, net		(16)	(46)
Earnings from continuing operations before income taxes	209	135	164
Earnings from continuing operations	209	135	164
Net earnings	209	135	164
Net earnings	209	135	164
Comprehensive Income
Net earnings	209	135	164
Other comprehensive income (loss), net	(176)	(546)	(401)
Total comprehensive income (loss)	33	(411)	(237)
Comprehensive income (loss) attributable to the Company	33	(411)	(237)
Guarantor Subsidiaries
Results of Operations
Equity earnings from subsidiaries	209	151	210
Earnings from continuing operations before income taxes	209	151	210
Earnings from continuing operations	209	151	210
Net earnings	209	151	210
Net earnings	209	151	210
Comprehensive Income
Net earnings	209	151	210
Other comprehensive income (loss), net	(176)	(546)	(401)
Total comprehensive income (loss)	33	(395)	(191)
Comprehensive income (loss) attributable to the Company	33	(395)	(191)
Non-Guarantor Subsidiaries
Results of Operations
Net sales	6,702	6,156	6,784
Cost of goods sold	(5,490)	(5,046)	(5,531)
Gross profit	1,212	1,110	1,253
Selling and administrative expense	(503)	(476)	(523)
Research, development and engineering expense	(65)	(64)	(63)
Net intercompany interest	(20)	(20)	(20)
Interest expense, net	(252)	(231)	(210)
Other equity earnings	60	60	64
Other expense, net	(76)	(95)	(148)
Earnings from continuing operations before income taxes	356	284	353
Provision for income taxes	(119)	(106)	(92)
Earnings from continuing operations	237	178	261
Loss from discontinued operations	(7)	(4)	(23)
Net earnings	230	174	238
Net (earnings) attributable to noncontrolling interests	(21)	(23)	(28)
Net earnings	209	151	210
Comprehensive Income
Net earnings	230	174	238
Other comprehensive income (loss), net	(159)	(539)	(394)
Total comprehensive income (loss)	71	(365)	(156)
Comprehensive income attributable to noncontrolling interests	(17)	(7)	(7)
Comprehensive income (loss) attributable to the Company	54	(372)	(163)
Eliminations
Results of Operations
Equity earnings from subsidiaries	(418)	(302)	(420)
Earnings from continuing operations before income taxes	(418)	(302)	(420)
Earnings from continuing operations	(418)	(302)	(420)
Net earnings	(418)	(302)	(420)
Net earnings	(418)	(302)	(420)
Comprehensive Income
Net earnings	(418)	(302)	(420)
Other comprehensive income (loss), net	352	1,092	802
Total comprehensive income (loss)	(66)	790	382
Comprehensive income (loss) attributable to the Company	$ (66)	$ 790	$ 382

Financial Information for Sub99

Financial Information for Subsidiary Guarantors and Non-Guarantors - Cash Flows (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash Flows
Cash provided by (utilized in) operating activities	$ 751	$ 608	$ 675
Cash utilized in investing activities	(417)	(2,748)	(455)
Cash provided by (utilized in) financing activities	(228)	2,057	(70)
Effect of exchange rate change on cash	(13)	(30)	(21)
Increase (decrease) in cash	93	(113)	129
Cash and cash equivalents at beginning of period	399	512	383
Cash and cash equivalents at end of period	492	399	512
Parent
Cash Flows
Cash provided by (utilized in) operating activities	(125)	(138)	(148)
Cash provided by (utilized in) financing activities	125	138	148
Non-Guarantor Subsidiaries
Cash Flows
Cash provided by (utilized in) operating activities	876	746	823
Cash utilized in investing activities	(417)	(2,748)	(455)
Cash provided by (utilized in) financing activities	(353)	1,919	(218)
Effect of exchange rate change on cash	(13)	(30)	(21)
Increase (decrease) in cash	93	(113)	129
Cash and cash equivalents at beginning of period	399	512	383
Cash and cash equivalents at end of period	$ 492	$ 399	$ 512

SCHEDULE II - VALUATION AND 100

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (CONSOLIDATED) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Allowances for losses and discounts on receivables
Reserves deducted from assets in the balance sheets:
Balance at beginning of period	$ 29	$ 34	$ 39
Additions
Charged to costs and expenses/charged to income	15	12	15
Other	(2)	(5)	(12)
Deductions	(10)	(12)	(8)
Balance at end of period	32	29	34
Valuation allowance on net deferred tax assets
Reserves deducted from assets in the balance sheets:
Balance at beginning of period	1,135	1,223	1,209
Additions
Charged to costs and expenses/charged to income	3	1	(2)
Other	(32)	5	55
Foreign currency translation	(3)	(20)	(15)
Other	(9)	(74)	(24)
Balance at end of period	$ 1,094	$ 1,135	$ 1,223